WO2018153556A1 - Cosmetic or dermatological preparations containing inorganic pigments which are coated with hydrophobic silica, and non-ionic emulsifiers - Google Patents
Cosmetic or dermatological preparations containing inorganic pigments which are coated with hydrophobic silica, and non-ionic emulsifiers Download PDFInfo
- Publication number
- WO2018153556A1 WO2018153556A1 PCT/EP2018/050269 EP2018050269W WO2018153556A1 WO 2018153556 A1 WO2018153556 A1 WO 2018153556A1 EP 2018050269 W EP2018050269 W EP 2018050269W WO 2018153556 A1 WO2018153556 A1 WO 2018153556A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- stearate
- coated
- preparations
- pigments
- group
- Prior art date
Links
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 title claims abstract description 44
- 238000002360 preparation method Methods 0.000 title claims abstract description 23
- 239000000377 silicon dioxide Substances 0.000 title claims abstract description 22
- 239000003995 emulsifying agent Substances 0.000 title claims abstract description 16
- 239000002537 cosmetic Substances 0.000 title claims abstract description 14
- 239000001023 inorganic pigment Substances 0.000 title description 13
- 230000002209 hydrophobic effect Effects 0.000 title 1
- 239000000049 pigment Substances 0.000 claims abstract description 39
- -1 fatty acid esters Chemical class 0.000 claims description 23
- 239000000203 mixture Substances 0.000 claims description 15
- 239000000126 substance Substances 0.000 claims description 15
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 14
- 239000000194 fatty acid Substances 0.000 claims description 14
- 229930195729 fatty acid Natural products 0.000 claims description 14
- NKEQOUMMGPBKMM-UHFFFAOYSA-N 2-hydroxy-2-[2-(2-hydroxy-3-octadecanoyloxypropoxy)-2-oxoethyl]butanedioic acid Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)COC(=O)CC(O)(C(O)=O)CC(O)=O NKEQOUMMGPBKMM-UHFFFAOYSA-N 0.000 claims description 8
- 150000002148 esters Chemical class 0.000 claims description 8
- RFVNOJDQRGSOEL-UHFFFAOYSA-N 2-hydroxyethyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCO RFVNOJDQRGSOEL-UHFFFAOYSA-N 0.000 claims description 6
- 229920002701 Polyoxyl 40 Stearate Polymers 0.000 claims description 6
- 150000004665 fatty acids Chemical class 0.000 claims description 6
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 claims description 5
- 238000004040 coloring Methods 0.000 claims description 5
- 229940061570 polyglyceryl-10 stearate Drugs 0.000 claims description 5
- 230000002087 whitening effect Effects 0.000 claims description 5
- NLMKTBGFQGKQEV-UHFFFAOYSA-N 2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-(2-hexadecoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethanol Chemical compound CCCCCCCCCCCCCCCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO NLMKTBGFQGKQEV-UHFFFAOYSA-N 0.000 claims description 4
- 150000002191 fatty alcohols Chemical class 0.000 claims description 3
- 150000004676 glycans Chemical class 0.000 claims description 3
- 229910044991 metal oxide Inorganic materials 0.000 claims description 3
- 150000004706 metal oxides Chemical class 0.000 claims description 3
- 239000002245 particle Substances 0.000 claims description 3
- 229920001282 polysaccharide Polymers 0.000 claims description 3
- 239000005017 polysaccharide Substances 0.000 claims description 3
- ICIDSZQHPUZUHC-UHFFFAOYSA-N 2-octadecoxyethanol Chemical compound CCCCCCCCCCCCCCCCCCOCCO ICIDSZQHPUZUHC-UHFFFAOYSA-N 0.000 claims description 2
- RMTFNDVZYPHUEF-XZBKPIIZSA-N 3-O-methyl-D-glucose Chemical compound O=C[C@H](O)[C@@H](OC)[C@H](O)[C@H](O)CO RMTFNDVZYPHUEF-XZBKPIIZSA-N 0.000 claims description 2
- 229940073669 ceteareth 20 Drugs 0.000 claims description 2
- 229940056318 ceteth-20 Drugs 0.000 claims description 2
- 229930182478 glucoside Natural products 0.000 claims description 2
- 150000008131 glucosides Chemical class 0.000 claims description 2
- 150000002772 monosaccharides Chemical class 0.000 claims description 2
- 150000002482 oligosaccharides Polymers 0.000 claims description 2
- 229940100460 peg-100 stearate Drugs 0.000 claims description 2
- 229940010735 steareth-12 Drugs 0.000 claims description 2
- 229940100459 steareth-20 Drugs 0.000 claims description 2
- 150000005846 sugar alcohols Polymers 0.000 claims description 2
- HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 claims 1
- SZYSLWCAWVWFLT-UTGHZIEOSA-N [(2s,3s,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)-2-[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxolan-2-yl]methyl octadecanoate Chemical compound O([C@@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@]1(COC(=O)CCCCCCCCCCCCCCCCC)O[C@H](CO)[C@@H](O)[C@@H]1O SZYSLWCAWVWFLT-UTGHZIEOSA-N 0.000 claims 1
- 229940075507 glyceryl monostearate Drugs 0.000 claims 1
- 238000010348 incorporation Methods 0.000 claims 1
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 claims 1
- 239000012875 nonionic emulsifier Substances 0.000 claims 1
- 229950011392 sorbitan stearate Drugs 0.000 claims 1
- 239000000839 emulsion Substances 0.000 description 25
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 15
- 239000003921 oil Substances 0.000 description 12
- 235000019198 oils Nutrition 0.000 description 12
- OSCJHTSDLYVCQC-UHFFFAOYSA-N 2-ethylhexyl 4-[[4-[4-(tert-butylcarbamoyl)anilino]-6-[4-(2-ethylhexoxycarbonyl)anilino]-1,3,5-triazin-2-yl]amino]benzoate Chemical compound C1=CC(C(=O)OCC(CC)CCCC)=CC=C1NC1=NC(NC=2C=CC(=CC=2)C(=O)NC(C)(C)C)=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=N1 OSCJHTSDLYVCQC-UHFFFAOYSA-N 0.000 description 11
- 239000012071 phase Substances 0.000 description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 11
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 9
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 9
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 8
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 5
- 239000004904 UV filter Substances 0.000 description 5
- 150000001298 alcohols Chemical class 0.000 description 5
- 235000011187 glycerol Nutrition 0.000 description 5
- XEEYBQQBJWHFJM-UHFFFAOYSA-N iron Substances [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 5
- 235000013980 iron oxide Nutrition 0.000 description 5
- 239000010445 mica Substances 0.000 description 5
- 229910052618 mica group Inorganic materials 0.000 description 5
- 229920006395 saturated elastomer Polymers 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 4
- 229920002125 Sokalan® Polymers 0.000 description 4
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 4
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- 125000004432 carbon atom Chemical group C* 0.000 description 4
- 238000004062 sedimentation Methods 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- 239000010936 titanium Substances 0.000 description 4
- 229910052719 titanium Inorganic materials 0.000 description 4
- 239000001993 wax Substances 0.000 description 4
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- WVDDGKGOMKODPV-UHFFFAOYSA-N Benzyl alcohol Chemical compound OCC1=CC=CC=C1 WVDDGKGOMKODPV-UHFFFAOYSA-N 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- FMRHJJZUHUTGKE-UHFFFAOYSA-N Ethylhexyl salicylate Chemical compound CCCCC(CC)COC(=O)C1=CC=CC=C1O FMRHJJZUHUTGKE-UHFFFAOYSA-N 0.000 description 3
- YBGZDTIWKVFICR-JLHYYAGUSA-N Octyl 4-methoxycinnamic acid Chemical compound CCCCC(CC)COC(=O)\C=C\C1=CC=C(OC)C=C1 YBGZDTIWKVFICR-JLHYYAGUSA-N 0.000 description 3
- 244000028344 Primula vulgaris Species 0.000 description 3
- 235000016311 Primula vulgaris Nutrition 0.000 description 3
- WGLPBDUCMAPZCE-UHFFFAOYSA-N Trioxochromium Chemical compound O=[Cr](=O)=O WGLPBDUCMAPZCE-UHFFFAOYSA-N 0.000 description 3
- 150000007513 acids Chemical class 0.000 description 3
- 229910052782 aluminium Inorganic materials 0.000 description 3
- 229910000423 chromium oxide Inorganic materials 0.000 description 3
- 239000003086 colorant Substances 0.000 description 3
- 239000006071 cream Substances 0.000 description 3
- 229920006037 cross link polymer Polymers 0.000 description 3
- 239000000975 dye Substances 0.000 description 3
- UVCJGUGAGLDPAA-UHFFFAOYSA-N ensulizole Chemical class N1C2=CC(S(=O)(=O)O)=CC=C2N=C1C1=CC=CC=C1 UVCJGUGAGLDPAA-UHFFFAOYSA-N 0.000 description 3
- 239000003925 fat Substances 0.000 description 3
- 235000019197 fats Nutrition 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 3
- FMJSMJQBSVNSBF-UHFFFAOYSA-N octocrylene Chemical compound C=1C=CC=CC=1C(=C(C#N)C(=O)OCC(CC)CCCC)C1=CC=CC=C1 FMJSMJQBSVNSBF-UHFFFAOYSA-N 0.000 description 3
- 230000037075 skin appearance Effects 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 239000002562 thickening agent Substances 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- DURPTKYDGMDSBL-UHFFFAOYSA-N 1-butoxybutane Chemical compound CCCCOCCCC DURPTKYDGMDSBL-UHFFFAOYSA-N 0.000 description 2
- QWGRWMMWNDWRQN-UHFFFAOYSA-N 2-methylpropane-1,3-diol Chemical compound OCC(C)CO QWGRWMMWNDWRQN-UHFFFAOYSA-N 0.000 description 2
- LEACJMVNYZDSKR-UHFFFAOYSA-N 2-octyldodecan-1-ol Chemical compound CCCCCCCCCCC(CO)CCCCCCCC LEACJMVNYZDSKR-UHFFFAOYSA-N 0.000 description 2
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 2
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 2
- GHVNFZFCNZKVNT-UHFFFAOYSA-N Decanoic acid Natural products CCCCCCCCCC(O)=O GHVNFZFCNZKVNT-UHFFFAOYSA-N 0.000 description 2
- 241000282414 Homo sapiens Species 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
- 239000007983 Tris buffer Substances 0.000 description 2
- HEAHZSUCFKFERC-LRVMPXQBSA-N [(2e)-2-[[4-[(z)-[7,7-dimethyl-3-oxo-4-(sulfomethyl)-2-bicyclo[2.2.1]heptanylidene]methyl]phenyl]methylidene]-7,7-dimethyl-3-oxo-4-bicyclo[2.2.1]heptanyl]methanesulfonic acid Chemical compound CC1(C)C2CCC1(CS(O)(=O)=O)C(=O)\C2=C/C(C=C1)=CC=C1\C=C/1C(=O)C2(CS(O)(=O)=O)CCC\1C2(C)C HEAHZSUCFKFERC-LRVMPXQBSA-N 0.000 description 2
- 150000001252 acrylic acid derivatives Chemical class 0.000 description 2
- 125000005250 alkyl acrylate group Chemical group 0.000 description 2
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 2
- 239000008346 aqueous phase Substances 0.000 description 2
- BTFJIXJJCSYFAL-UHFFFAOYSA-N arachidyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCO BTFJIXJJCSYFAL-UHFFFAOYSA-N 0.000 description 2
- 229940073609 bismuth oxychloride Drugs 0.000 description 2
- 229960001631 carbomer Drugs 0.000 description 2
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Natural products OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 229940008099 dimethicone Drugs 0.000 description 2
- 239000004205 dimethyl polysiloxane Substances 0.000 description 2
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 2
- 229960000655 ensulizole Drugs 0.000 description 2
- 239000000945 filler Substances 0.000 description 2
- 229940075529 glyceryl stearate Drugs 0.000 description 2
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 2
- PMMXXYHTOMKOAZ-UHFFFAOYSA-N hexadecyl 7-methyloctanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)CCCCCC(C)C PMMXXYHTOMKOAZ-UHFFFAOYSA-N 0.000 description 2
- AMWRITDGCCNYAT-UHFFFAOYSA-L hydroxy(oxo)manganese;manganese Chemical compound [Mn].O[Mn]=O.O[Mn]=O AMWRITDGCCNYAT-UHFFFAOYSA-L 0.000 description 2
- 229910052742 iron Inorganic materials 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 229940100573 methylpropanediol Drugs 0.000 description 2
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 2
- 229960001679 octinoxate Drugs 0.000 description 2
- 229960000601 octocrylene Drugs 0.000 description 2
- 239000012860 organic pigment Substances 0.000 description 2
- BWOROQSFKKODDR-UHFFFAOYSA-N oxobismuth;hydrochloride Chemical compound Cl.[Bi]=O BWOROQSFKKODDR-UHFFFAOYSA-N 0.000 description 2
- 238000005191 phase separation Methods 0.000 description 2
- 229960005323 phenoxyethanol Drugs 0.000 description 2
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 2
- 229920000058 polyacrylate Polymers 0.000 description 2
- 229920001296 polysiloxane Polymers 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- 239000011591 potassium Substances 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 229920002545 silicone oil Polymers 0.000 description 2
- 229920002379 silicone rubber Polymers 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 239000004408 titanium dioxide Substances 0.000 description 2
- 150000003626 triacylglycerols Chemical class 0.000 description 2
- 239000000230 xanthan gum Substances 0.000 description 2
- 229920001285 xanthan gum Polymers 0.000 description 2
- 235000010493 xanthan gum Nutrition 0.000 description 2
- 229940082509 xanthan gum Drugs 0.000 description 2
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 1
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- PDHSAQOQVUXZGQ-JKSUJKDBSA-N (2r,3s)-2-(3,4-dihydroxyphenyl)-3-methoxy-3,4-dihydro-2h-chromene-5,7-diol Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2OC)=CC=C(O)C(O)=C1 PDHSAQOQVUXZGQ-JKSUJKDBSA-N 0.000 description 1
- PDQICKRFOKDJCH-INIZCTEOSA-N (2s)-6-amino-2-(dodecanoylamino)hexanoic acid Chemical class CCCCCCCCCCCC(=O)N[C@H](C(O)=O)CCCCN PDQICKRFOKDJCH-INIZCTEOSA-N 0.000 description 1
- WBYWAXJHAXSJNI-VOTSOKGWSA-M .beta-Phenylacrylic acid Natural products [O-]C(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-M 0.000 description 1
- NKJOXAZJBOMXID-UHFFFAOYSA-N 1,1'-Oxybisoctane Chemical compound CCCCCCCCOCCCCCCCC NKJOXAZJBOMXID-UHFFFAOYSA-N 0.000 description 1
- JYEUMXHLPRZUAT-UHFFFAOYSA-N 1,2,3-triazine Chemical compound C1=CN=NN=C1 JYEUMXHLPRZUAT-UHFFFAOYSA-N 0.000 description 1
- SBASXUCJHJRPEV-UHFFFAOYSA-N 2-(2-methoxyethoxy)ethanol Chemical group COCCOCCO SBASXUCJHJRPEV-UHFFFAOYSA-N 0.000 description 1
- IYAZLDLPUNDVAG-UHFFFAOYSA-N 2-(benzotriazol-2-yl)-4-(2,4,4-trimethylpentan-2-yl)phenol Chemical compound CC(C)(C)CC(C)(C)C1=CC=C(O)C(N2N=C3C=CC=CC3=N2)=C1 IYAZLDLPUNDVAG-UHFFFAOYSA-N 0.000 description 1
- JGUMTYWKIBJSTN-UHFFFAOYSA-N 2-ethylhexyl 4-[[4,6-bis[4-(2-ethylhexoxycarbonyl)anilino]-1,3,5-triazin-2-yl]amino]benzoate Chemical compound C1=CC(C(=O)OCC(CC)CCCC)=CC=C1NC1=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=N1 JGUMTYWKIBJSTN-UHFFFAOYSA-N 0.000 description 1
- NPSJHQMIVNJLNN-UHFFFAOYSA-N 2-ethylhexyl 4-nitrobenzoate Chemical compound CCCCC(CC)COC(=O)C1=CC=C([N+]([O-])=O)C=C1 NPSJHQMIVNJLNN-UHFFFAOYSA-N 0.000 description 1
- LWLRMRFJCCMNML-UHFFFAOYSA-N 2-ethylhexyl dodecanoate Chemical compound CCCCCCCCCCCC(=O)OCC(CC)CCCC LWLRMRFJCCMNML-UHFFFAOYSA-N 0.000 description 1
- SFAAOBGYWOUHLU-UHFFFAOYSA-N 2-ethylhexyl hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(CC)CCCC SFAAOBGYWOUHLU-UHFFFAOYSA-N 0.000 description 1
- 239000004808 2-ethylhexylester Substances 0.000 description 1
- MWKPHOIHTLQZIY-UHFFFAOYSA-N 2-hexyldecyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(CCCCCC)CCCCCCCC MWKPHOIHTLQZIY-UHFFFAOYSA-N 0.000 description 1
- WSSJONWNBBTCMG-UHFFFAOYSA-N 2-hydroxybenzoic acid (3,3,5-trimethylcyclohexyl) ester Chemical compound C1C(C)(C)CC(C)CC1OC(=O)C1=CC=CC=C1O WSSJONWNBBTCMG-UHFFFAOYSA-N 0.000 description 1
- XBNFOAOCJWQKPX-UHFFFAOYSA-N 2-hydroxypropane-1,2,3-tricarboxylic acid;octadecanoic acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O.CCCCCCCCCCCCCCCCCC(O)=O XBNFOAOCJWQKPX-UHFFFAOYSA-N 0.000 description 1
- YDQUROLTIDVHRK-UHFFFAOYSA-N 2-hydroxypropane-1,2,3-tricarboxylic acid;propane-1,2,3-triol Chemical compound OCC(O)CO.OC(=O)CC(O)(C(O)=O)CC(O)=O YDQUROLTIDVHRK-UHFFFAOYSA-N 0.000 description 1
- RUDXBXPTJPNTSO-UHFFFAOYSA-N 2-octyldodecyl hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(CCCCCCCC)CCCCCCCCCC RUDXBXPTJPNTSO-UHFFFAOYSA-N 0.000 description 1
- UIVPNOBLHXUKDX-UHFFFAOYSA-N 3,5,5-trimethylhexyl 3,5,5-trimethylhexanoate Chemical compound CC(C)(C)CC(C)CCOC(=O)CC(C)CC(C)(C)C UIVPNOBLHXUKDX-UHFFFAOYSA-N 0.000 description 1
- AGNTUZCMJBTHOG-UHFFFAOYSA-N 3-[3-(2,3-dihydroxypropoxy)-2-hydroxypropoxy]propane-1,2-diol Chemical class OCC(O)COCC(O)COCC(O)CO AGNTUZCMJBTHOG-UHFFFAOYSA-N 0.000 description 1
- ANZUDYZHSVGBRF-UHFFFAOYSA-N 3-ethylnonane-1,2,3-triol Chemical compound CCCCCCC(O)(CC)C(O)CO ANZUDYZHSVGBRF-UHFFFAOYSA-N 0.000 description 1
- IHZXTIBMKNSJCJ-UHFFFAOYSA-N 3-{[(4-{[4-(dimethylamino)phenyl](4-{ethyl[(3-sulfophenyl)methyl]amino}phenyl)methylidene}cyclohexa-2,5-dien-1-ylidene)(ethyl)azaniumyl]methyl}benzene-1-sulfonate Chemical compound C=1C=C(C(=C2C=CC(C=C2)=[N+](C)C)C=2C=CC(=CC=2)N(CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=CC=1N(CC)CC1=CC=CC(S(O)(=O)=O)=C1 IHZXTIBMKNSJCJ-UHFFFAOYSA-N 0.000 description 1
- NSWKKBKROCMOHA-UHFFFAOYSA-N 4-(naphthalen-1-yldiazenyl)naphthalen-1-ol Chemical compound Oc1ccc(N=Nc2cccc3ccccc23)c2ccccc12 NSWKKBKROCMOHA-UHFFFAOYSA-N 0.000 description 1
- NGJJZCPADSICRI-UHFFFAOYSA-N 4-[[4,6-bis(4-carboxyanilino)-1,3,5-triazin-2-yl]amino]benzoic acid Chemical compound C1=CC(C(=O)O)=CC=C1N=C(NC(=NC=1C=CC(=CC=1)C(O)=O)N1)NC1=NC1=CC=C(C(O)=O)C=C1 NGJJZCPADSICRI-UHFFFAOYSA-N 0.000 description 1
- MGVSKQQYUFPTPT-UHFFFAOYSA-N 4-bicyclo[2.2.1]heptanyl(oxo)methanesulfonic acid Chemical compound C1CC2CCC1(C(=O)S(=O)(=O)O)C2 MGVSKQQYUFPTPT-UHFFFAOYSA-N 0.000 description 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- SJIDAAGFCNIAJP-UHFFFAOYSA-N 6-methylheptyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCCCCC(C)C SJIDAAGFCNIAJP-UHFFFAOYSA-N 0.000 description 1
- XUVVLJKRLAXOKZ-UHFFFAOYSA-N 7-methyloctyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCCCCCC(C)C XUVVLJKRLAXOKZ-UHFFFAOYSA-N 0.000 description 1
- KGKQNDQDVZQTAG-UHFFFAOYSA-N 8-methylnonyl 2,2-dimethylpropanoate Chemical compound CC(C)CCCCCCCOC(=O)C(C)(C)C KGKQNDQDVZQTAG-UHFFFAOYSA-N 0.000 description 1
- 229910018072 Al 2 O 3 Inorganic materials 0.000 description 1
- 235000019489 Almond oil Nutrition 0.000 description 1
- 235000021537 Beetroot Nutrition 0.000 description 1
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 1
- 244000017106 Bixa orellana Species 0.000 description 1
- XFNSLUBOOLTEEG-XBGXTARASA-N C(CCCCCCCCCCCCCCCCC)(=O)O.C(CCCCCCCCCCCCCCCCC)(=O)O.C(C(O)CO)C(=O)[C@H](O)[C@@](O)([C@H](O)[C@H](O)CO)C Chemical compound C(CCCCCCCCCCCCCCCCC)(=O)O.C(CCCCCCCCCCCCCCCCC)(=O)O.C(C(O)CO)C(=O)[C@H](O)[C@@](O)([C@H](O)[C@H](O)CO)C XFNSLUBOOLTEEG-XBGXTARASA-N 0.000 description 1
- 239000005632 Capric acid (CAS 334-48-5) Substances 0.000 description 1
- 239000005635 Caprylic acid (CAS 124-07-2) Substances 0.000 description 1
- WBYWAXJHAXSJNI-SREVYHEPSA-N Cinnamic acid Chemical compound OC(=O)\C=C/C1=CC=CC=C1 WBYWAXJHAXSJNI-SREVYHEPSA-N 0.000 description 1
- ACTIUHUUMQJHFO-UHFFFAOYSA-N Coenzym Q10 Natural products COC1=C(OC)C(=O)C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UHFFFAOYSA-N 0.000 description 1
- 239000004971 Cross linker Substances 0.000 description 1
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 1
- CMBYOWLFQAFZCP-UHFFFAOYSA-N Hexyl dodecanoate Chemical compound CCCCCCCCCCCC(=O)OCCCCCC CMBYOWLFQAFZCP-UHFFFAOYSA-N 0.000 description 1
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 description 1
- VVQNEPGJFQJSBK-UHFFFAOYSA-N Methyl methacrylate Chemical compound COC(=O)C(C)=C VVQNEPGJFQJSBK-UHFFFAOYSA-N 0.000 description 1
- 229920000881 Modified starch Polymers 0.000 description 1
- 229920000572 Nylon 6/12 Polymers 0.000 description 1
- XGEXTFUFRSZXLW-UHFFFAOYSA-N OS(=O)(=O)OS(=O)(=O)S(O)(=O)=O Chemical compound OS(=O)(=O)OS(=O)(=O)S(O)(=O)=O XGEXTFUFRSZXLW-UHFFFAOYSA-N 0.000 description 1
- 206010033546 Pallor Diseases 0.000 description 1
- 235000019482 Palm oil Nutrition 0.000 description 1
- 235000019483 Peanut oil Nutrition 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 235000019484 Rapeseed oil Nutrition 0.000 description 1
- 229910004298 SiO 2 Inorganic materials 0.000 description 1
- 206010040954 Skin wrinkling Diseases 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- FHNINJWBTRXEBC-UHFFFAOYSA-N Sudan III Chemical compound OC1=CC=C2C=CC=CC2=C1N=NC(C=C1)=CC=C1N=NC1=CC=CC=C1 FHNINJWBTRXEBC-UHFFFAOYSA-N 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 235000019486 Sunflower oil Nutrition 0.000 description 1
- 206010043189 Telangiectasia Diseases 0.000 description 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 1
- BZUVPTAFNJMPEZ-CLFAGFIQSA-N [(z)-docos-13-enyl] (z)-docos-13-enoate Chemical compound CCCCCCCC\C=C/CCCCCCCCCCCCOC(=O)CCCCCCCCCCC\C=C/CCCCCCCC BZUVPTAFNJMPEZ-CLFAGFIQSA-N 0.000 description 1
- TXZRBCSUYLEATA-GALHSAGASA-N [(z)-docos-13-enyl] (z)-octadec-9-enoate Chemical compound CCCCCCCC\C=C/CCCCCCCCCCCCOC(=O)CCCCCCC\C=C/CCCCCCCC TXZRBCSUYLEATA-GALHSAGASA-N 0.000 description 1
- SZAMSYKZCSDVBH-CLFAGFIQSA-N [(z)-octadec-9-enyl] (z)-docos-13-enoate Chemical compound CCCCCCCC\C=C/CCCCCCCCCCCC(=O)OCCCCCCCC\C=C/CCCCCCCC SZAMSYKZCSDVBH-CLFAGFIQSA-N 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 1
- 239000008168 almond oil Substances 0.000 description 1
- 125000000129 anionic group Chemical group 0.000 description 1
- 235000012665 annatto Nutrition 0.000 description 1
- 239000010362 annatto Substances 0.000 description 1
- 230000001153 anti-wrinkle effect Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- UHHXUPJJDHEMGX-UHFFFAOYSA-K azanium;manganese(3+);phosphonato phosphate Chemical compound [NH4+].[Mn+3].[O-]P([O-])(=O)OP([O-])([O-])=O UHHXUPJJDHEMGX-UHFFFAOYSA-K 0.000 description 1
- IRERQBUNZFJFGC-UHFFFAOYSA-L azure blue Chemical compound [Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Al+3].[Al+3].[Al+3].[Al+3].[Al+3].[Al+3].[S-]S[S-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-] IRERQBUNZFJFGC-UHFFFAOYSA-L 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 235000019445 benzyl alcohol Nutrition 0.000 description 1
- 235000013734 beta-carotene Nutrition 0.000 description 1
- 239000011648 beta-carotene Substances 0.000 description 1
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 1
- 229960002747 betacarotene Drugs 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- ULBTUVJTXULMLP-UHFFFAOYSA-N butyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCCC ULBTUVJTXULMLP-UHFFFAOYSA-N 0.000 description 1
- 102220360498 c.118_119delAGinsCC Human genes 0.000 description 1
- 229920003086 cellulose ether Polymers 0.000 description 1
- CETPSERCERDGAM-UHFFFAOYSA-N ceric oxide Chemical compound O=[Ce]=O CETPSERCERDGAM-UHFFFAOYSA-N 0.000 description 1
- 229910000422 cerium(IV) oxide Inorganic materials 0.000 description 1
- 125000003901 ceryl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- QFSKIUZTIHBWFR-UHFFFAOYSA-N chromium;hydrate Chemical compound O.[Cr] QFSKIUZTIHBWFR-UHFFFAOYSA-N 0.000 description 1
- 229930016911 cinnamic acid Natural products 0.000 description 1
- 235000013985 cinnamic acid Nutrition 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 239000003240 coconut oil Substances 0.000 description 1
- 235000019864 coconut oil Nutrition 0.000 description 1
- 239000007957 coemulsifier Substances 0.000 description 1
- 235000017471 coenzyme Q10 Nutrition 0.000 description 1
- ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 description 1
- 229940110767 coenzyme Q10 Drugs 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 238000005336 cracking Methods 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- SASYSVUEVMOWPL-NXVVXOECSA-N decyl oleate Chemical compound CCCCCCCCCCOC(=O)CCCCCCC\C=C/CCCCCCCC SASYSVUEVMOWPL-NXVVXOECSA-N 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 150000001983 dialkylethers Chemical class 0.000 description 1
- 150000002009 diols Chemical class 0.000 description 1
- KPUWHANPEXNPJT-UHFFFAOYSA-N disiloxane Chemical class [SiH3]O[SiH3] KPUWHANPEXNPJT-UHFFFAOYSA-N 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- ZMUCVNSKULGPQG-UHFFFAOYSA-N dodecanedioic acid;hexane-1,6-diamine Chemical compound NCCCCCCN.OC(=O)CCCCCCCCCCC(O)=O ZMUCVNSKULGPQG-UHFFFAOYSA-N 0.000 description 1
- DLAHAXOYRFRPFQ-UHFFFAOYSA-N dodecyl benzoate Chemical compound CCCCCCCCCCCCOC(=O)C1=CC=CC=C1 DLAHAXOYRFRPFQ-UHFFFAOYSA-N 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 238000004043 dyeing Methods 0.000 description 1
- HEAHZSUCFKFERC-UHFFFAOYSA-N ecamsule Chemical compound CC1(C)C2CCC1(CS(O)(=O)=O)C(=O)C2=CC(C=C1)=CC=C1C=C1C(=O)C2(CS(O)(=O)=O)CCC1C2(C)C HEAHZSUCFKFERC-UHFFFAOYSA-N 0.000 description 1
- 229960003747 ecamsule Drugs 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000010696 ester oil Substances 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- ZZUFCTLCJUWOSV-UHFFFAOYSA-N furosemide Chemical compound C1=C(Cl)C(S(=O)(=O)N)=CC(C(O)=O)=C1NCC1=CC=CO1 ZZUFCTLCJUWOSV-UHFFFAOYSA-N 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 229940087068 glyceryl caprylate Drugs 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- ACCCMOQWYVYDOT-UHFFFAOYSA-N hexane-1,1-diol Chemical compound CCCCCC(O)O ACCCMOQWYVYDOT-UHFFFAOYSA-N 0.000 description 1
- 238000000265 homogenisation Methods 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 1
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 1
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- VBMVTYDPPZVILR-UHFFFAOYSA-N iron(2+);oxygen(2-) Chemical class [O-2].[Fe+2] VBMVTYDPPZVILR-UHFFFAOYSA-N 0.000 description 1
- JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 1
- 229940100554 isononyl isononanoate Drugs 0.000 description 1
- XUGNVMKQXJXZCD-UHFFFAOYSA-N isopropyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(C)C XUGNVMKQXJXZCD-UHFFFAOYSA-N 0.000 description 1
- 229940089456 isopropyl stearate Drugs 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 229940119170 jojoba wax Drugs 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- HCWCAKKEBCNQJP-UHFFFAOYSA-N magnesium orthosilicate Chemical compound [Mg+2].[Mg+2].[O-][Si]([O-])([O-])[O-] HCWCAKKEBCNQJP-UHFFFAOYSA-N 0.000 description 1
- 239000000391 magnesium silicate Substances 0.000 description 1
- 229910052919 magnesium silicate Inorganic materials 0.000 description 1
- 235000019792 magnesium silicate Nutrition 0.000 description 1
- 229910052748 manganese Inorganic materials 0.000 description 1
- 239000011572 manganese Substances 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- WBYWAXJHAXSJNI-UHFFFAOYSA-N methyl p-hydroxycinnamate Natural products OC(=O)C=CC1=CC=CC=C1 WBYWAXJHAXSJNI-UHFFFAOYSA-N 0.000 description 1
- CXKWCBBOMKCUKX-UHFFFAOYSA-M methylene blue Chemical compound [Cl-].C1=CC(N(C)C)=CC2=[S+]C3=CC(N(C)C)=CC=C3N=C21 CXKWCBBOMKCUKX-UHFFFAOYSA-M 0.000 description 1
- 229960000907 methylthioninium chloride Drugs 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 235000019426 modified starch Nutrition 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- 239000007764 o/w emulsion Substances 0.000 description 1
- OEIJHBUUFURJLI-UHFFFAOYSA-N octane-1,8-diol Chemical compound OCCCCCCCCO OEIJHBUUFURJLI-UHFFFAOYSA-N 0.000 description 1
- 229960002446 octanoic acid Drugs 0.000 description 1
- YBGZDTIWKVFICR-UHFFFAOYSA-N octinoxate Chemical compound CCCCC(CC)COC(=O)C=CC1=CC=C(OC)C=C1 YBGZDTIWKVFICR-UHFFFAOYSA-N 0.000 description 1
- 229960003921 octisalate Drugs 0.000 description 1
- WCJLCOAEJIHPCW-UHFFFAOYSA-N octyl 2-hydroxybenzoate Chemical class CCCCCCCCOC(=O)C1=CC=CC=C1O WCJLCOAEJIHPCW-UHFFFAOYSA-N 0.000 description 1
- BARWIPMJPCRCTP-UHFFFAOYSA-N oleic acid oleyl ester Natural products CCCCCCCCC=CCCCCCCCCOC(=O)CCCCCCCC=CCCCCCCCC BARWIPMJPCRCTP-UHFFFAOYSA-N 0.000 description 1
- 229940120511 oleyl erucate Drugs 0.000 description 1
- BARWIPMJPCRCTP-CLFAGFIQSA-N oleyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCCOC(=O)CCCCCCC\C=C/CCCCCCCC BARWIPMJPCRCTP-CLFAGFIQSA-N 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- RVTZCBVAJQQJTK-UHFFFAOYSA-N oxygen(2-);zirconium(4+) Chemical compound [O-2].[O-2].[Zr+4] RVTZCBVAJQQJTK-UHFFFAOYSA-N 0.000 description 1
- 239000003346 palm kernel oil Substances 0.000 description 1
- 235000019865 palm kernel oil Nutrition 0.000 description 1
- 239000002540 palm oil Substances 0.000 description 1
- 239000000312 peanut oil Substances 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- 229920003217 poly(methylsilsesquioxane) Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920005862 polyol Polymers 0.000 description 1
- 150000003077 polyols Chemical class 0.000 description 1
- PZQSQRCNMZGWFT-QXMHVHEDSA-N propan-2-yl (z)-octadec-9-enoate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC(C)C PZQSQRCNMZGWFT-QXMHVHEDSA-N 0.000 description 1
- ZPWFUIUNWDIYCJ-UHFFFAOYSA-N propan-2-yl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC(C)C ZPWFUIUNWDIYCJ-UHFFFAOYSA-N 0.000 description 1
- 238000011321 prophylaxis Methods 0.000 description 1
- GHBFNMLVSPCDGN-UHFFFAOYSA-N rac-1-monooctanoylglycerol Chemical compound CCCCCCCC(=O)OCC(O)CO GHBFNMLVSPCDGN-UHFFFAOYSA-N 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 229940100486 rice starch Drugs 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- 229910052814 silicon oxide Inorganic materials 0.000 description 1
- 230000009759 skin aging Effects 0.000 description 1
- 206010040882 skin lesion Diseases 0.000 description 1
- 231100000444 skin lesion Toxicity 0.000 description 1
- 229940047670 sodium acrylate Drugs 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000002600 sunflower oil Substances 0.000 description 1
- 230000002889 sympathetic effect Effects 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 208000009056 telangiectasis Diseases 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 238000011282 treatment Methods 0.000 description 1
- 150000003918 triazines Chemical class 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-O triethanolammonium Chemical class OCC[NH+](CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-O 0.000 description 1
- 235000013799 ultramarine blue Nutrition 0.000 description 1
- 230000024883 vasodilation Effects 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
- 229910001928 zirconium oxide Inorganic materials 0.000 description 1
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
- A61Q1/02—Preparations containing skin colorants, e.g. pigments
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/0241—Containing particulates characterized by their shape and/or structure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/06—Emulsions
- A61K8/062—Oil-in-water emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/25—Silicon; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
- A61K8/375—Esters of carboxylic acids the alcohol moiety containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
- A61K8/604—Alkylpolyglycosides; Derivatives thereof, e.g. esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/86—Polyethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/52—Stabilizers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/60—Particulates further characterized by their structure or composition
- A61K2800/61—Surface treated
- A61K2800/62—Coated
- A61K2800/621—Coated by inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/60—Particulates further characterized by their structure or composition
- A61K2800/65—Characterized by the composition of the particulate/core
- A61K2800/651—The particulate/core comprising inorganic material
Definitions
- the invention relates to cosmetic or dermatological preparations containing inorganic pigments coated with hydrophilic silica and nonionic emulsifiers.
- decorative cosmetics derives from the Latin “decoratio” - the highlighting of the beautiful - with the help of dyes, individual parts of the body, especially on the face, are highlighted and color inconsistencies are lessened Give appearance, refresh pale skin, compensate for color irregularities of the skin as well as emphasize eyes and lips.
- a particular embodiment is the so-called Foundation.
- Foundation is liquid or semisolid make-up that is mostly skin colored and applied to the face. They give a uniform, healthy, tinted or reddish appearance. Their color is usually obtained by a mixture of pigments from the group of inorganic white, colored and / or colored pigments.
- the prior art requires relatively large amounts of these inorganic whitening, coloring and / or colored pigments. The larger the proportion of these pigments in the preparation, the better the skin appearance is balanced. Redness and other visual skin irregularities are masked.
- a disadvantage of the prior art is the fact that foundations based on O / W emulsions (oil-in-water emulsions) can only be formulated with a relatively low pigment content, since with an increasing content of insoluble particles or pigments Instabilities or rheological changes of the emulsion, such as decrease in viscosity occur.
- the desired decorative effects can only be achieved with sufficiently high amounts of pigments.
- a cosmetic O / W emulsion containing a) at least one pigment from the group of inorganic whitening, dyeing and / or colored pigments which are coated with hydrophilic silica and
- Particularly advantageous inorganic pigments which are coated with hydrophilic silica are the so-called “Primrose” pigments from Miyoshi Kasei Inc.
- Preferred representatives of these silica-coated, hydrophilic, inorganic pigments have an average particle size of 1 .0 - 3.0 ⁇ m and have the following typical composition: 85.0-90.0% of inorganic pigments as the core and 10.0-15.0% of silicon dioxide (silica) as coating.
- Typical metal oxides used in the inorganic pigments are titanium dioxide, iron oxide, chromium oxide and manganese oxide.
- the different oxidation states of the metal oxide, especially the iron oxide, are responsible for the different colors, with the following classes, which are summarized in the so-called Color Index: Cl 77499 (black), Cl 77491 (red), Cl 77492 (yellow).
- Cl 77499 black
- Cl 77491 red
- Cl 77492 yellow
- These inorganic whitening, coloring and / or coloring pigments are combined with each other in the present invention to obtain a certain hue.
- Cosmetic or dermatological preparations according to the invention preferably contain from 0.01 to 50% by weight, preferably from 0.05 to 30% by weight, particularly preferably from 0.1 to 20% by weight, of one or more of the pigments of the invention Group of inorganic whitening, coloring or colored pigments which are coated with hydrophilic silica, based on the total composition of the preparations.
- nonionic emulsifiers are preferably a) partial fatty acid esters and fatty acid esters of polyhydric alcohols and their ethoxylated derivatives (eg glyceryl monostearates, sorbitan stearates, glyceryl stearate citrate, sucrose stearates) and b) ethoxylated fatty alcohols and fatty acids, preferably PEG-100 stearate, PEG-40 Steatrate, ceteareth-20, ceteth-20, steareth-20, ceteareth-12, ceteth-12, steareth-12 and esters of mono-, oligo- or polysaccharides with fatty acids, preferably cetearyl glucoside and methyl glucose distearate. c) fatty acid esters of oligoglycerols and mixtures of the substances mentioned under a), b) and c).
- polyhydric alcohols and their ethoxylated derivatives egly
- glyceryl stearate citrate polyglyceryl-3-methyl glucose distearate, polyglyceryl stearate and / or PEG-40 stearate.
- PGMS polyglyceryl-3-methyl-glucose distearate
- PEG-40 Stearate is available, inter alia, from Evonik Industries under the trade name TEGO Acid S40P.
- Glyceryl stearate citrate (2-hydroxy-1,2,3-propanetricarboxylic acid 1,2,3-propanetriol monoocta-decanoate, INCI Glyceryl Stearate Citrate) is the citric acid ester of glyceryl stearate and is available from several manufacturers under the names Imwitor 370 or 372 , Polyglyceryl-10 stearate is available under the trade designation Polyaldo 10-1 -S from Lonza.
- Cosmetic or dermatological preparations according to the invention preferably comprise 0.01-20% by weight, preferably 0.05-10% by weight, particularly preferably 0.1-5% by weight of one or more of the nonionic emulsifiers according to the invention, based on the total composition of the preparations, in particular one or more substances selected from one or more of the groups mentioned under a) to c), most preferably one or more substances selected from the group glyceryl stearate citrate, polyglyceryl-3-methylglucose distearate , Polyglyceryl-10 stearate and / or PEG-40 stearate.
- Emulsions are advantageous dosage forms in the sense of the present invention, e.g. in the form of a cream, a lotion, a cosmetic milk are advantageous and contain e.g. Fats, oils, waxes and / or other fatty substances, as well as water and one or more emulsifiers, as they are commonly used for such a type of formulation.
- the cosmetic or dermatological preparation in the sense of the present invention is a solution or emulsion or dispersion, it is possible to use as solvent:
- Oils such as triglycerides of capric or caprylic acid, silicone oils;
- Fats, waxes and other natural and synthetic fats preferably esters of fatty acids with lower C-number alcohols, e.g. with isopropanol, propylene glycol or glycerol, or esters of fatty alcohols with alkanoic acids of low C number or with
- Fatty acids three dimensionally crosslinked organopolysiloxanes such as siloxane nelastomer;
- Alcohols, diols or polyols of low C number, and their ethers preferably ethanol, isopropanol, propylene glycol, glycerol, hexanediol, octanediol, ethylhexylglycerol, glycerylcaprylate, ethylene glycol, ethylene glycol monoethyl or monobutyl ether, propylene glycol monomethyl, butylene glycol, methylpropanediol, monoethyl or monobutyl ether, diethylene glycol monomethyl or monoethyl ether and analogous products.
- the oil phase of the emulsions, oleogels or hydrodispersions or lipodispersions in the context of the present invention is advantageously selected from the group of esters of saturated and / or unsaturated, branched and / or unbranched alkanecarboxylic acids having a chain length of 3 to 30 carbon atoms and saturated and / or or unsaturated, branched and / or unbranched alcohols having a chain length of 3 to 30 carbon atoms, from the group of esters of aromatic carboxylic acids and saturated and / or unsaturated, branched and / or unbranched alcohols having a chain length of 3 to 30 carbon atoms.
- ester oils can then advantageously be selected from the group isopropyl myristate, isopropyl palmitate, isopropyl stearate, isopropyl oleate, n-butyl stearate, n-hexyl laurate, n-decyl oleate, isooctyl stearate, isononyl stearate, isononyl isononanoate, cetearyl isononanoate, isodecyl neopentanoate, 2-ethylhexyl palmitate, 2 Ethyl hexyl laurate, 2-hexyl decyl stearate, 2-octyl dodecyl palmitate, oleyl oleate, oleyl erucate, erucyl oleate, erucyl erucate and also synthetic, semi-synthetic and natural mixtures of such esters,
- the oil phase can be advantageously selected from the group of branched and unbranched hydrocarbons and waxes, the silicone oils, the dialkyl ethers, the group of saturated or unsaturated, branched or unbranched alcohols, and the fatty acid triglycerides, in particular the triglycerol esters of saturated and / or unsaturated, branched and / or unbranched alkanecarboxylic acids of a chain length of 8 to 24, in particular 12 to 18 carbon atoms.
- the fatty acid triglycerides can be advantageously selected from the group of synthetic, semi-synthetic and natural oils, e.g. Olive oil, sunflower oil, soybean oil, peanut oil, rapeseed oil, almond oil, palm oil, coconut oil, palm kernel oil and the like.
- Usual colorants which are suitable for use as cosmetic or dermatological compositions in the context of the present invention are lipophilic dyes (eg Sudan Red, DB & C Red 17, DB & C Green 6, ⁇ -carotene, Sudan brown, DB & C Yellow 1 1, DB & C Violet 2, DB & C Orange 5 or Annatto), hydrophilic dyes (eg beetroot juice or methylene blue), pearlescent pigments and blends of such colorants.
- lipophilic dyes eg Sudan Red, DB & C Red 17, DB & C Green 6, ⁇ -carotene, Sudan brown, DB & C Yellow 1 1, DB & C Violet 2, DB & C Orange 5 or Annatto
- hydrophilic dyes eg beetroot juice or methylene blue
- pearlescent pigments eg beetroot juice or methylene blue
- the pigments may be white or colored, goniochromatic or non-goniochromatic, inorganic and / or organic, coated or uncoated.
- the inorganic pigments include titanium dioxide which is optionally surface-treated, zirconium oxide (ZrO 2), zinc oxide (ZnO), iron oxide (eg Fe 2 O 3), silicon oxide (SiO 2), manganese (eg MnO), aluminum ( Al 2 O 3), or ceria (eg, Ce 2 O 3), and iron oxide, chromium oxide, manganese violet, ultramarine blue, chromium hydrate, and iron blue
- the pearlescent pigments may be exemplified by white pearlescent pigments such as mica coated with titanium or bismuth oxychloride, colored pearlescent pigments such as titanium mica with iron oxides, titanium mica especially iron blue or chromium oxide mica, titanium mica having an organic pigment of the type mentioned above and pearlescent pigments based on Bismuth oxychloride.
- the pigments can also be used advantageously in the form of commercially available oily or aqueous predispersions. Dispersants and / or solubilizers may advantageously be added to these predispersions.
- silicone elastomers according to the invention are crosslinked, optionally substituted organopolysiloxanes.
- the crosslinking may have been carried out by means of all common methods and crosslinkers.
- silicone elastomers can be used in powder form, such as, for example, e.g. EP-9701 or EP 9801 to Dow Corning.
- the preparation contains one or more fillers.
- the fillers are selected from the group of the compounds nylon 6/12, silica, silica dimethyl silylates, aluminum starch octenylsuccinates, dimethicone crosspolymer, dimethicone / vinyldimethicone crosspolymer, methyl methacrylate large polymer, talc, rice starch and all starch derivatives, lauroyl lysines , Magnesium silicate and / or polymethylsilsesquioxane.
- the aqueous phase of the preparations according to the invention may advantageously contain one or more thickening agents which may be advantageously selected from the group of silica, aluminum silicates, polysaccharides or their derivatives, e.g. Hyaluronic acid, xanthan gum, cellulose ethers such as e.g.
- Hydroxypropylmethylcellu- lose particularly advantageous from the group of polyacrylates, preferably a polyacrylate from the group of so-called Carbopols, for example, Carbopols types 980, 981, 1382, 2984, 5984, Ultrez 10, ETD 2020, acrylates / C 10-30 alkyl acrylates Crosspolymer, sodium acrylate copolymer, carbomer, either individually or in combination.
- Carbopols for example, Carbopols types 980, 981, 1382, 2984, 5984, Ultrez 10, ETD 2020, acrylates / C 10-30 alkyl acrylates
- Crosspolymer sodium acrylate copolymer, carbomer, either individually or in combination.
- Inventive formulations which z. B. known anti-wrinkle agents such as flavone glycosides (especially ⁇ -glycosyl rutin), coenzyme Q10, vitamin E and / or derivatives and the like, are particularly advantageous for the prophylaxis and treatment of cosmetic or dermatological skin lesions, as z. B. in skin aging such as dryness, roughness and formation of dryness lines, itching, reduced refatting (eg after washing), visible vasodilation (telangiectasia, cuperosis), slackness and development of wrinkles and fine lines, local hypo-, hypo- and false pigmentation (eg, age spots), increased susceptibility to mechanical stress (eg, cracking), and the like). Furthermore, they are advantageous against the appearance of dry or rough skin.
- Preparations in the context of the present invention may preferably contain at least one further UV-A, UV-B and / or broad-spectrum filter substance.
- the formulations may, although not necessary, optionally also contain one or more organic and / or inorganic pigments as UV filter substances, which may be present in the water and / or the oil phase.
- ICI octocrylene
- 2-ethylhexyl 2-hydroxybenzoate 2-ethylhexyl salicylate, octyl salicylate, INCI: octyl Salicylates
- esters of cinnamic acid
- UV-A filter substances for the purposes of the present invention are dibenzoylmeter derivatives, in particular 4- (tert-butyl) -4'-methoxydibenzoylmethane (CAS No. 70356-09-1), which has been sold by Givaudan under the trademark Parsol ® 1789 and sold by Merck under the trade name Eusolex® 9020.
- UV filter substances in the context of the present invention are sulfonated, water-soluble UV filters, such as. B .:
- Advantageous UV filter substances for the purposes of the present invention are also so-called broadband filters, i. Filter substances that absorb both UV-A and UV-B radiation.
- Advantageous broadband filters or UV-B filter substances are, for example, triazine derivatives, such as. B.
- Diethylhexylbutylamidotriazone (INCI: diethylhexylbutamidotriazone), which is available under the trade name UVASORB HEB from Sigma 3V;
- An advantageous broadband filter in the context of the present invention is also the 2,2'-methyl-bis (6- (2H-benzotriazol-2-yl) -4- (1,1,3,3-tetramethylbutyl) phenol ), which is available under the trade name Tinosorb® M from CIBA-Chemikalien GmbH.
- the lipophilic phase eg oils, waxes
- thickeners, pigments and the aqueous phase are weighed in separately, the nonionic O / W emulsifier being added to the lipophilic phase (oil phase), while the anionic, water-soluble emulsifiers were added to the water phase.
- the oil phase is heated to 75 ° C in a water bath to the emulsifier and to dissolve the coemulsifier.
- the water phase is also heated to 75 ° C with stirring and then it is slowly added after the addition of the thickener phase with intensive stirring to the oil phase, wherein a coarse emulsion is formed.
- the silica-coated inorganic pigments are intensively homogenized in a separate vessel in about 100 ml of a solution of glycerol and water with a high-speed mixer (eg an ESG wand) for about 2 minutes and then submerged to about 60 ° C warm emulsion Stirring added.
- the emulsion is then homogenized a first time and then neutralized with sodium hydroxide solution to a pH of pH 6.5 - 7.3. After the emulsion has cooled to room temperature, a second homogenization is carried out.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Chemical & Material Sciences (AREA)
- Inorganic Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dispersion Chemistry (AREA)
- Emergency Medicine (AREA)
- Cosmetics (AREA)
Abstract
The invention relates to cosmetic and dermatological preparations containing a) at least one pigment from the group of inorganic white, coloured or multi-coloured pigments which are coated with hydrophilic silica and b) one or more non-ionic emulsifiers.
Description
Beschreibung description
Kosmetische oder dermatologische Zubereitungen mit einem Gehalt an anorganischen Pigmente, welche mit hydrophilem Silica beschichtet sind, und nichtionischen Cosmetic or dermatological preparations containing inorganic pigments coated with hydrophilic silica, and nonionic
Emulgatoren emulsifiers
Die Erfindung betrifft kosmetische oder dermatologische Zubereitungen mit einem Gehalt an anorganischen Pigmenten, welche mit hydrophilem Silica beschichtet sind, und nichtionischen Emulgatoren. The invention relates to cosmetic or dermatological preparations containing inorganic pigments coated with hydrophilic silica and nonionic emulsifiers.
Der Wunsch, schön und attraktiv auszusehen, ist seit Tausenden von Jahren in den Menschen verwurzelt. Auch wenn das Schönheitsideal im Laufe der Zeit Wandlungen erfahren hat, so ist das Streben nach einem makellosen Äußeren, immer das Ziel der Menschen gewesen, da ein sympathisches Erscheinungsbild ihr Selbstwertgefühl und die Anziehungskraft auf ihre Mitmenschen erhöht. The desire to look beautiful and attractive has been rooted in people for thousands of years. Even though the ideal of beauty has undergone changes over time, the pursuit of an impeccable appearance has always been the goal of man, since a sympathetic appearance enhances their self-esteem and attraction to their fellow human beings.
Der Begriff der Dekorativen Kosmetik leitet vom lateinischen„decoratio" - das Hervorheben des Schönen - ab. Meist werden dabei mit Hilfe von Farbstoffen einzelne Körperpartien, insbesondere im Gesicht, hervorgehoben und farbliche Uneinheitlichkeiten abgemildert. Das Gesichts-Make-up soll der Gesichtshaut ein natürliches Aussehen verleihen, blasse Haut auffrischen, farbliche Unregelmäßigkeiten der Haut ausgleichen sowie Augen und Lippen besonders betonen. The term "decorative cosmetics" derives from the Latin "decoratio" - the highlighting of the beautiful - with the help of dyes, individual parts of the body, especially on the face, are highlighted and color inconsistencies are lessened Give appearance, refresh pale skin, compensate for color irregularities of the skin as well as emphasize eyes and lips.
Neben Gesichtspudern und Rouge als pulverförmigen Kosmetika sowie stiftförmigen Zubereitungen werden hierzu cremeförmige Präparate, wie Tagescremes und Creme-Make-up auf Emulsionsbasis oder Hydrodispersionsbasis verwendet. Eine besondere Ausführungsform ist die sogenannte Foundation. Als Foundation bezeichnet man dabei flüssige oder halbfeste Make-up-Präparate, die meist Hautfarben sind und auf das Gesicht aufgetragen werden. Sie verleihen ein gleichmäßiges, gesundes, getöntes oder rötliches Aussehen. Ihren Farbton erhalten diese Zubereitungen in der Regel durch eine Mischung aus Pigmenten aus der Gruppe der anorganischen Weiß-, Färb- und/oder Buntpigmente. Um ein gleichmäßiges
Hautbild zu erzeugen, sind nach dem Stand der Technik relativ große Mengen an diesen anorganischen Weiß-, Färb- und/oder Buntpigmenten erforderlich. Je größer der Anteil dieser Pigmente in der Zubereitung ist, desto besser wird das Hautbild ausgeglichen. Rötungen und andere optische Hautunregelmäßigkeiten werden überdeckt. In addition to facial powders and rouge as powdered cosmetics and stick-shaped preparations cream-like preparations, such as day creams and cream make-up based on emulsion or hydrodispersion base are used. A particular embodiment is the so-called Foundation. Foundation is liquid or semisolid make-up that is mostly skin colored and applied to the face. They give a uniform, healthy, tinted or reddish appearance. Their color is usually obtained by a mixture of pigments from the group of inorganic white, colored and / or colored pigments. To a uniform To produce a skin appearance, the prior art requires relatively large amounts of these inorganic whitening, coloring and / or colored pigments. The larger the proportion of these pigments in the preparation, the better the skin appearance is balanced. Redness and other visual skin irregularities are masked.
Nachteilig am Stande der Technik ist jedoch der Umstand, dass Foundations auf der Basis von O/W-Emulsionen (ÖI-in-Wasser-Emulsionen) nur mit einem relativ geringen Pigmentgehalt formuliert werden können, da bei einem zunehmendem Gehalt an unlöslichen Partikeln oder Pigmenten Instabilitäten bzw rheologische Veränderungen der Emulsion, wie zum Beispiel Abnahme der Viskosität, auftreten. Auf der anderen Seite lassen sich jedoch die erwünschten dekorativen Effekte nur mit ausreichend hohen Mengen an Pigmenten erzielen. A disadvantage of the prior art, however, is the fact that foundations based on O / W emulsions (oil-in-water emulsions) can only be formulated with a relatively low pigment content, since with an increasing content of insoluble particles or pigments Instabilities or rheological changes of the emulsion, such as decrease in viscosity occur. On the other hand, however, the desired decorative effects can only be achieved with sufficiently high amounts of pigments.
Es war daher die Aufgabe der vorliegenden Erfindung, eine Foundation auf der Basis einer O/W-Emulsion zu entwickeln, die eine hohe Stabilität aufweist, sich gut auf der Haut verteilen lässt und nach dem Auftragen auf die Haut zu einem gleichmäßigen Hautbild führt und alle optischen Unregelmäßigkeiten wirkungsvoll überdeckt. It was therefore an object of the present invention to develop a foundation based on an O / W emulsion, which has a high stability, can be distributed well on the skin and after application to the skin leads to a uniform skin appearance and all optical irregularities effectively covered.
Überraschend gelöst wird die Aufgabe durch eine kosmetische O/W-Emulsion enthaltend a) mindestens ein Pigment aus der Gruppe der anorganischen Weiß-, Färb- und/oder Buntpigmente, welche mit hydrophilem Silica beschichtet sind und, The object is surprisingly achieved by a cosmetic O / W emulsion containing a) at least one pigment from the group of inorganic whitening, dyeing and / or colored pigments which are coated with hydrophilic silica and
b) einen oder mehrere nichtionische Emulgatoren. b) one or more nonionic emulsifiers.
Besonders vorteilhafte anorganische Pigmente, welche mit hydrophilem Silica beschichtet sind, stellen die sogenannten„Primrose" Pigmente von der Firma Miyoshi Kasei Inc. dar. Particularly advantageous inorganic pigments which are coated with hydrophilic silica are the so-called "Primrose" pigments from Miyoshi Kasei Inc.
Bevorzugte Vertreter dieser mit Silica beschichteten, hydrophilen, anorganischen Pigmente haben eine durchschnittlichen Teilchengröße von 1 .0 - 3.0 μηι und haben folgende typische Zusammensetzung: 85.0 - 90.0 % anorganische Pigmente als Kern und 10.0 - 15.0 % Silici- umdioxid (Silica) als Beschichtung. Preferred representatives of these silica-coated, hydrophilic, inorganic pigments have an average particle size of 1 .0 - 3.0 μm and have the following typical composition: 85.0-90.0% of inorganic pigments as the core and 10.0-15.0% of silicon dioxide (silica) as coating.
Typische Metalloxide, die in den anorganischen Pigmenten verwendet werden, sind Titandioxid, Eisenoxid, Chromoxid und Manganoxid. Die unterschiedliche Oxidationszustände des Metalloxids, vor allem des Eisenoxids, sind verantwortlich für die unterschiedliche Farbgebung, wobei es folgende Klassen gibt, die im sogenannten Color Index zusammengefasst werden: Cl 77499 (Schwarz), Cl 77491 (Rot), Cl 77492 (Gelb). Diese anorganischen Weiß-, Färb- und/oder Buntpigmente werden mit einander in der vorliegenden Erfindung kombiniert, um einen bestimmten Farbton zu erzielen.
Bevorzugt enthalten kosmetische oder dermatologische Zubereitungen gemäß der Erfindung 0,01 - 50 Gew.-%, bevorzugt 0,05 - 30 Gew.-%, besonders bevorzugt 0,1 - 20 Gew.-% an einem oder mehreren der erfindungsgemäßen Pigmente aus der Gruppe der anorganischen Weiß-, Färb- oder Buntpigmente, welche mit hydrophilem Silica beschichtet sind, bezogen auf die Gesamtzusammensetzung der Zubereitungen. Typical metal oxides used in the inorganic pigments are titanium dioxide, iron oxide, chromium oxide and manganese oxide. The different oxidation states of the metal oxide, especially the iron oxide, are responsible for the different colors, with the following classes, which are summarized in the so-called Color Index: Cl 77499 (black), Cl 77491 (red), Cl 77492 (yellow). These inorganic whitening, coloring and / or coloring pigments are combined with each other in the present invention to obtain a certain hue. Cosmetic or dermatological preparations according to the invention preferably contain from 0.01 to 50% by weight, preferably from 0.05 to 30% by weight, particularly preferably from 0.1 to 20% by weight, of one or more of the pigments of the invention Group of inorganic whitening, coloring or colored pigments which are coated with hydrophilic silica, based on the total composition of the preparations.
Unter den nichtionischen Emulgatoren befinden sich vorzugsweise a) Partialfettsäureester und Fettsäureester mehrwertiger Alkohole und deren ethoxilierte Derivate (z. B. Glycerylmonostearate, Sorbitanstearate, Glycerylstearatcitrat Sucrose Stearate) und b) ethoxylierte Fettalkohole und Fettsäuren, bevorzugt PEG-100-Stearat, PEG-40-Stea- rat, Ceteareth-20, Ceteth-20, Steareth-20, Ceteareth-12, Ceteth-12, Steareth-12 sowie Ester aus Mono-, Oligo- oder Polysacchariden mit Fettsäuren, bevorzugt Cetearylglu- cosid und Methylglucosedistearat. c) Fettsäureester von Oligoglycerinen sowie Gemische aus den unter a), b) und c) bezeichneten Substanzen. Among the nonionic emulsifiers are preferably a) partial fatty acid esters and fatty acid esters of polyhydric alcohols and their ethoxylated derivatives (eg glyceryl monostearates, sorbitan stearates, glyceryl stearate citrate, sucrose stearates) and b) ethoxylated fatty alcohols and fatty acids, preferably PEG-100 stearate, PEG-40 Steatrate, ceteareth-20, ceteth-20, steareth-20, ceteareth-12, ceteth-12, steareth-12 and esters of mono-, oligo- or polysaccharides with fatty acids, preferably cetearyl glucoside and methyl glucose distearate. c) fatty acid esters of oligoglycerols and mixtures of the substances mentioned under a), b) and c).
Besonders bevorzugt sind Glycerylstearatcitrat, Polyglyceryl-3 Methylglucosedistearat, Poly- glyceryl-10 Stearat und/oder PEG-40-Stearat. Particularly preferred are glyceryl stearate citrate, polyglyceryl-3-methyl glucose distearate, polyglyceryl stearate and / or PEG-40 stearate.
Ein bevorzugter Vertreter des„Polyglyceryl-3 Methylglucosedistearat" (PGMS) ist unter der Warenbezeichnung Tego® Care 450 von der Firma Evonik Industries erhältlich. A preferred representative of "polyglyceryl-3-methyl-glucose distearate" (PGMS) is available under the trade name Tego® Care 450 from Evonik Industries.
PEG-40 Stearat ist unter anderem bei der Firma Evonik Industries unter dem Handelsnamen TEGO Acid S40 P erhältlich. PEG-40 Stearate is available, inter alia, from Evonik Industries under the trade name TEGO Acid S40P.
Glycerylstearatcitrat, (2-Hydroxy-1 ,2,3-propantricarbonsäure-1 ,2,3-propantriolmonoocta-de- canoat, INCI Glyceryl Stearate Citrate) ist der Citronensäureester des Glycerylstearates und wird von verschiedenen Herstellern unter den Bezeichnungen Imwitor 370 oder 372 angeboten.
Polyglyceryl-10 Stearat ist unter der Warenbezeichnung Polyaldo 10-1 -S von der Firma Lonza erhältlich. Glyceryl stearate citrate, (2-hydroxy-1,2,3-propanetricarboxylic acid 1,2,3-propanetriol monoocta-decanoate, INCI Glyceryl Stearate Citrate) is the citric acid ester of glyceryl stearate and is available from several manufacturers under the names Imwitor 370 or 372 , Polyglyceryl-10 stearate is available under the trade designation Polyaldo 10-1 -S from Lonza.
Bevorzugt enthalten kosmetische oder dermatologische Zubereitungen gemäß der Erfindung 0,01 - 20 Gew.-%, bevorzugt 0,05 - 10 Gew.-%, besonders bevorzugt 0,1 - 5 Gew.-% an einem oder mehreren der erfindungsgemäßen nichtionischen Emulgatoren, bezogen auf die Gesamtzusammensetzung der Zubereitungen, insbesondere eine oder mehrere Substanzen, gewählt aus einer oder mehrerer der unter a) bis c) genannten Gruppen, ganz besonders bevorzugt eine oder mehrere Substanzen, gewählt aus der Gruppe Glycerylstearatcitrat, Poly- glyceryl-3-Methylglucose Distearat, Polyglyceryl-10 Stearat und/oder PEG-40-Stearat. Cosmetic or dermatological preparations according to the invention preferably comprise 0.01-20% by weight, preferably 0.05-10% by weight, particularly preferably 0.1-5% by weight of one or more of the nonionic emulsifiers according to the invention, based on the total composition of the preparations, in particular one or more substances selected from one or more of the groups mentioned under a) to c), most preferably one or more substances selected from the group glyceryl stearate citrate, polyglyceryl-3-methylglucose distearate , Polyglyceryl-10 stearate and / or PEG-40 stearate.
Emulsionen sind vorteilhafte Darreichungsformen im Sinne der vorliegenden Erfindung, z.B. in Form einer Creme, einer Lotion, einer kosmetischen Milch sind vorteilhaft und enthalten z.B. Fette, Öle, Wachse und/oder andere Fettkörper, sowie Wasser und einen oder mehrere Emulgatoren, wie sie üblicherweise für einen solchen Typ der Formulierung verwendet werden. Emulsions are advantageous dosage forms in the sense of the present invention, e.g. in the form of a cream, a lotion, a cosmetic milk are advantageous and contain e.g. Fats, oils, waxes and / or other fatty substances, as well as water and one or more emulsifiers, as they are commonly used for such a type of formulation.
Sofern die kosmetische oder dermatologische Zubereitung im Sinne der vorliegenden Erfindung eine Lösung oder Emulsion oder Dispersion darstellt, können als Lösungsmittel verwendet werden: If the cosmetic or dermatological preparation in the sense of the present invention is a solution or emulsion or dispersion, it is possible to use as solvent:
Wasser oder wässrige Lösungen Water or aqueous solutions
Öle, wie Triglyceride der Caprin- oder der Caprylsäure, Siliconöle; Oils, such as triglycerides of capric or caprylic acid, silicone oils;
Fette, Wachse und andere natürliche und synthetische Fettkörper, vorzugsweise Ester von Fettsäuren mit Alkoholen niedriger C-Zahl, z.B. mit Isopropanol, Propylenglykol o- der Glycerin, oder Ester von Fettalkoholen mit Alkansäuren niedriger C-Zahl oder mit Fats, waxes and other natural and synthetic fats, preferably esters of fatty acids with lower C-number alcohols, e.g. with isopropanol, propylene glycol or glycerol, or esters of fatty alcohols with alkanoic acids of low C number or with
Fettsäuren, drei dimensional vernetzte Organopolysiloxane wie zum Beispiel Siloxa- nelastomer; Fatty acids, three dimensionally crosslinked organopolysiloxanes such as siloxane nelastomer;
Alkohole, Diole oder Polyole niedriger C-Zahl, sowie deren Ether, vorzugsweise Ethanol, Isopropanol, Propylenglykol, Glycerin, Hexandiol, Octandiol, Ethylhexylglycerin, Glycerylcaprylat, Ethylenglykol, Ethylenglykolmonoethyl- oder -monobutylether, Propy- lenglykolmonomethyl, Butylenglykol, Methylpropandiol, -monoethyl- oder -monobutylether, Diethylenglykolmonomethyl- oder -monoethylether und analoge Produkte. Alcohols, diols or polyols of low C number, and their ethers, preferably ethanol, isopropanol, propylene glycol, glycerol, hexanediol, octanediol, ethylhexylglycerol, glycerylcaprylate, ethylene glycol, ethylene glycol monoethyl or monobutyl ether, propylene glycol monomethyl, butylene glycol, methylpropanediol, monoethyl or monobutyl ether, diethylene glycol monomethyl or monoethyl ether and analogous products.
Insbesondere werden Gemische der vorstehend genannten Lösungsmittel verwendet. Bei alkoholischen Lösungsmitteln kann Wasser ein weiterer Bestandteil sein.
Die Ölphase der Emulsionen, Oleogele bzw. Hydrodispersionen oder Lipodispersionen im Sinne der vorliegenden Erfindung wird vorteilhaft gewählt aus der Gruppe der Ester aus gesättigten und/oder ungesättigten, verzweigten und/oder unverzweigten Alkancarbonsäuren einer Kettenlänge von 3 bis 30 C-Atomen und gesättigten und/oder ungesättigten, verzweigten und/oder unverzweigten Alkoholen einer Kettenlänge von 3 bis 30 C-Atomen, aus der Gruppe der Ester aus aromatischen Carbonsäuren und gesättigten und/oder ungesättigten, verzweigten und/oder unverzweigten Alkoholen einer Kettenlänge von 3 bis 30 C-Atomen. Solche Esteröle können dann vorteilhaft gewählt werden aus der Gruppe Isopropylmyristat, Isopropylpalmitat, Isopropylstearat, Isopropyloleat, n-Butylstearat, n-Hexyllaurat, n-Decy- loleat, Isooctylstearat, Isononylstearat, Isononylisononanoat, Cetearylisononanoat, Isodecyl- neopentanoat, 2-Ethylhexylpalmitat, 2-Ethylhexyllaurat, 2-Hexyldecylstearat, 2-Octyldodecyl- palmitat, Oleyloleat, Oleylerucat, Erucyloleat, Erucylerucat sowie synthetische, halbsynthetische und natürliche Gemische solcher Ester, z.B. Jojobaöl. In particular, mixtures of the abovementioned solvents are used. For alcoholic solvents, water can be another ingredient. The oil phase of the emulsions, oleogels or hydrodispersions or lipodispersions in the context of the present invention is advantageously selected from the group of esters of saturated and / or unsaturated, branched and / or unbranched alkanecarboxylic acids having a chain length of 3 to 30 carbon atoms and saturated and / or or unsaturated, branched and / or unbranched alcohols having a chain length of 3 to 30 carbon atoms, from the group of esters of aromatic carboxylic acids and saturated and / or unsaturated, branched and / or unbranched alcohols having a chain length of 3 to 30 carbon atoms. Such ester oils can then advantageously be selected from the group isopropyl myristate, isopropyl palmitate, isopropyl stearate, isopropyl oleate, n-butyl stearate, n-hexyl laurate, n-decyl oleate, isooctyl stearate, isononyl stearate, isononyl isononanoate, cetearyl isononanoate, isodecyl neopentanoate, 2-ethylhexyl palmitate, 2 Ethyl hexyl laurate, 2-hexyl decyl stearate, 2-octyl dodecyl palmitate, oleyl oleate, oleyl erucate, erucyl oleate, erucyl erucate and also synthetic, semi-synthetic and natural mixtures of such esters, for example jojoba oil.
Ferner kann die Ölphase vorteilhaft gewählt werden aus der Gruppe der verzweigten und unverzweigten Kohlenwasserstoffe und -wachse, der Silkonöle, der Dialkylether, der Gruppe der gesättigten oder ungesättigten, verzweigten oder unverzweigten Alkohole, sowie der Fettsäuretriglyceride, namentlich der Triglycerinester gesättigter und/oder ungesättigter, verzweigter und/oder unverzweigter Alkancarbonsäuren einer Kettenlänge von 8 bis 24, insbesondere 12 bis 18 C-Atomen. Die Fettsäuretriglyceride können beispielsweise vorteilhaft gewählt werden aus der Gruppe der synthetischen, halbsynthetischen und natürlichen Öle, z.B. Olivenöl, Sonnenblumenöl, Sojaöl, Erdnussöl, Rapsöl, Mandelöl, Palmöl, Kokosöl, Palm- kernöl und dergleichen mehr. Furthermore, the oil phase can be advantageously selected from the group of branched and unbranched hydrocarbons and waxes, the silicone oils, the dialkyl ethers, the group of saturated or unsaturated, branched or unbranched alcohols, and the fatty acid triglycerides, in particular the triglycerol esters of saturated and / or unsaturated, branched and / or unbranched alkanecarboxylic acids of a chain length of 8 to 24, in particular 12 to 18 carbon atoms. For example, the fatty acid triglycerides can be advantageously selected from the group of synthetic, semi-synthetic and natural oils, e.g. Olive oil, sunflower oil, soybean oil, peanut oil, rapeseed oil, almond oil, palm oil, coconut oil, palm kernel oil and the like.
Übliche Farbmittel, welche sich für die Verwendung als kosmetische oder dermatologische Zusammensetzungen im Sinne der vorliegenden Erfindung eignen, sind lipophile Farbstoffe (z.B. Sudanrot, DB&C Red 17, DB&C Green 6, ß-Carotin, Sudanbraun, DB&C Yellow 1 1 , DB&C Violet 2, DB&C Orange 5 oder Annatto) , hydrophile Farbstoffe (z.B. Rote Beete-Saft oder Methylenblau), Perlglanzpigmenten sowie Abmischungen aus solchen Farbmitteln. Usual colorants which are suitable for use as cosmetic or dermatological compositions in the context of the present invention are lipophilic dyes (eg Sudan Red, DB & C Red 17, DB & C Green 6, β-carotene, Sudan brown, DB & C Yellow 1 1, DB & C Violet 2, DB & C Orange 5 or Annatto), hydrophilic dyes (eg beetroot juice or methylene blue), pearlescent pigments and blends of such colorants.
Die Pigmente können weiß oder farbig, goniochromatisch oder nicht goniochromatisch, anorganisch und/oder organisch, beschichtet oder nicht beschichtet sein. Zu den anorganischen Pigmenten, die angegeben werden können, gehören Titandioxid, das optional oberflächenbehandelt ist, Zirconiumoxid (Zr02), Zinkoxid (ZnO), Eisenoxid (z.B. Fe203), Siliciumoxid (Si02), Mangans (z. B. MnO), Aluminiums (AI203), oder Ceroxid (z. B. Ce203), sowie Eisenoxid, Chromoxid, Manganviolett, Ultramarinblau, Chromhydrat und Eisenblau
Die Perlglanzpigmente können unter weißen Perlglanzpigmenten, wie Glimmer, der mit Titan oder mit Bismutoxidchlorid überzogen ist, farbigen Perlglanzpigmenten, wie Titanglimmer mit Eisenoxiden, Titanglimmer mit vor allem Eisenblau oder Chromoxid, Titanglimmer mit einem organischen Pigment vom oben erwähnten Typ und Perlglanzpigmente auf der Basis von Bismutoxidchlorid ausgewählt werden. The pigments may be white or colored, goniochromatic or non-goniochromatic, inorganic and / or organic, coated or uncoated. Among the inorganic pigments which may be mentioned include titanium dioxide which is optionally surface-treated, zirconium oxide (ZrO 2), zinc oxide (ZnO), iron oxide (eg Fe 2 O 3), silicon oxide (SiO 2), manganese (eg MnO), aluminum ( Al 2 O 3), or ceria (eg, Ce 2 O 3), and iron oxide, chromium oxide, manganese violet, ultramarine blue, chromium hydrate, and iron blue The pearlescent pigments may be exemplified by white pearlescent pigments such as mica coated with titanium or bismuth oxychloride, colored pearlescent pigments such as titanium mica with iron oxides, titanium mica especially iron blue or chromium oxide mica, titanium mica having an organic pigment of the type mentioned above and pearlescent pigments based on Bismuth oxychloride.
Die Pigmente können vorteilhaft im Sinne der vorliegenden Erfindung auch in Form kommerziell erhältlicher öliger oder wässriger Vordispersionen zur Anwendung kommen. Diesen Vordispersionen können vorteilhaft Dispergierhilfsmittel und/oder Solubilisations-vermittler zugesetzt sein. Within the meaning of the present invention, the pigments can also be used advantageously in the form of commercially available oily or aqueous predispersions. Dispersants and / or solubilizers may advantageously be added to these predispersions.
Bei den erfindungsgemäßen Silikonelastomeren handelt es sich um vernetzte, ggf. substituierte Organopolysiloxane. Die Vernetzung kann mittels aller gängigen Verfahren und Vernetzern durchgeführt worden sein. Besonders vorteilhaft im Sinne der vorliegenden Erfindung können Silikonelastomeren in Puder Form eingesetzt werden, wie beispielsweise z.B. EP- 9701 oder EP-9801 von Dow Corning. The silicone elastomers according to the invention are crosslinked, optionally substituted organopolysiloxanes. The crosslinking may have been carried out by means of all common methods and crosslinkers. Particularly advantageous for the purposes of the present invention, silicone elastomers can be used in powder form, such as, for example, e.g. EP-9701 or EP 9801 to Dow Corning.
Ferner ist es erfindungsgemäß vorteilhaft, wenn die Zubereitung eine oder mehrere Füllstoffe enthält. Erfindungsgemäß bevorzugt werden die Füllstoffe gewählt aus der Gruppe der Verbindungen Nylon 6/12, Silica, Silica Dimethyl Silylate, Aluminiumstärkeoctenylsuccinate, Di- methicon-Crosspolymer, Dimethicon/Vinyldimethicon-Crosspolymer, Methylmethacrylat- Grosspolymer, Talkum, Reisstärke und alle Stärke Derivate, Lauroyl Lysine, Magnesium Silikat und/oder Polymethylsilsesquioxane. Furthermore, it is advantageous according to the invention if the preparation contains one or more fillers. According to the invention, the fillers are selected from the group of the compounds nylon 6/12, silica, silica dimethyl silylates, aluminum starch octenylsuccinates, dimethicone crosspolymer, dimethicone / vinyldimethicone crosspolymer, methyl methacrylate large polymer, talc, rice starch and all starch derivatives, lauroyl lysines , Magnesium silicate and / or polymethylsilsesquioxane.
Die wässrige Phase der erfindungsgemäßen Zubereitungen enthält gegebenenfalls vorteilhaft ein oder mehrere Verdickungsmittel, welches oder welche vorteilhaft gewählt werden können aus der Gruppe Siliciumdioxid, Aluminiumsilikate, Polysaccharide bzw. deren Derivate, z.B. Hyaluronsäure, Xanthangummi, Celluloseether wie z.B. Hydroxypropylmethylcellu- lose, besonders vorteilhaft aus der Gruppe der Polyacrylate, bevorzugt ein Polyacrylat aus der Gruppe der sogenannten Carbopole, beispielsweise Carbopole der Typen 980, 981 , 1382, 2984, 5984, Ultrez 10, ETD 2020, Acrylates/C 10-30 Alkyl Acrylates Crosspolymer, Sodium Acrylates Copolymer, Carbomer, jeweils einzeln oder in Kombination. The aqueous phase of the preparations according to the invention may advantageously contain one or more thickening agents which may be advantageously selected from the group of silica, aluminum silicates, polysaccharides or their derivatives, e.g. Hyaluronic acid, xanthan gum, cellulose ethers such as e.g. Hydroxypropylmethylcellu- lose, particularly advantageous from the group of polyacrylates, preferably a polyacrylate from the group of so-called Carbopols, for example, Carbopols types 980, 981, 1382, 2984, 5984, Ultrez 10, ETD 2020, acrylates / C 10-30 alkyl acrylates Crosspolymer, sodium acrylate copolymer, carbomer, either individually or in combination.
Erfindungsgemäße Rezepturen, welche z. B. bekannte Anti-Falten Wirkstoffe wie Flavon-gly- coside (insbesondere α-Glycosylrutin), Coenzym Q10, Vitamin E und/oder Derivate und dergleichen enthalten, eignen sich insbesondere vorteilhaft zur Prophylaxe und Behandlung kosmetischer oder dermatologischer Hautveränderungen, wie sie z. B. bei der Hautalterung
auftreten (wie beispielsweise Trockenheit, Rauigkeit und Ausbildung von Trockenheitsfält- chen, Juckreiz, verminderte Rückfettung (z. B. nach dem Waschen), sichtbare Gefäßerweiterungen (Teleangiektasien, Cuperosis), Schlaffheit und Ausbildung von Falten und Fältchen, lokale Hyper-, Hypo- und Fehlpigmentierungen (z. B. Altersflecken), vergrößerte Anfälligkeit gegenüber mechanischem Stress (z. B. Rissigkeit) und dergleichen). Weiterhin vorteilhaft eignen sie sich gegen das Erscheinungsbild der trockenen bzw. rauen Haut. Inventive formulations which z. B. known anti-wrinkle agents such as flavone glycosides (especially α-glycosyl rutin), coenzyme Q10, vitamin E and / or derivatives and the like, are particularly advantageous for the prophylaxis and treatment of cosmetic or dermatological skin lesions, as z. B. in skin aging such as dryness, roughness and formation of dryness lines, itching, reduced refatting (eg after washing), visible vasodilation (telangiectasia, cuperosis), slackness and development of wrinkles and fine lines, local hypo-, hypo- and false pigmentation (eg, age spots), increased susceptibility to mechanical stress (eg, cracking), and the like). Furthermore, they are advantageous against the appearance of dry or rough skin.
Zubereitungen im Sinne der vorliegenden Erfindung können vorzugsweise mindestens eine weitere UV-A-, UV-B- und/oder Breitbandfiltersubstanz enthalten. Die Formulierungen können, obgleich nicht notwendig, gegebenenfalls auch ein oder mehrere organische und/oder anorganische Pigmente als UV-Filtersubstanzen enthalten, welche in der Wasser- und/oder der Ölphase vorliegen können. Preparations in the context of the present invention may preferably contain at least one further UV-A, UV-B and / or broad-spectrum filter substance. The formulations may, although not necessary, optionally also contain one or more organic and / or inorganic pigments as UV filter substances, which may be present in the water and / or the oil phase.
Besonders vorteilhafte bei Raumtemperatur flüssige UV-Filtersubstanzen im Sinne der vorliegenden Erfindung sind 2-Ethylhexyl-2-cyano-3,3-diphenylacrylat (INCI: Octocrylene), 2- Ethylhexyl-2-hydroxybenzoat (2-Ethylhexylsalicylat, Octylsalicylat, INCI: Octyl Salicylate) und Ester der Zimtsäure, vorzugsweise 4-Methoxyzimtsäure(2-ethylhexyl)ester (2-Ethylhe- xyl-4-methoxycinnamat, INCI: Octyl Methoxycinnamate). Particularly advantageous UV filter substances which are liquid at room temperature for the purposes of the present invention are 2-ethylhexyl 2-cyano-3,3-diphenylacrylate (INCI: octocrylene), 2-ethylhexyl 2-hydroxybenzoate (2-ethylhexyl salicylate, octyl salicylate, INCI: octyl Salicylates) and esters of cinnamic acid, preferably 4-methoxycinnamic acid (2-ethylhexyl) ester (2-ethylhexyl-4-methoxycinnamate, INCI: octyl methoxycinnamate).
Vorteilhafte UV-A-Filtersubstanzen im Sinne der vorliegenden Erfindung sind Dibenzoylmet- handerivate, insbesondere das 4-(tert.-Butyl)-4'-methoxydibenzoylmethan (CAS-Nr. 70356- 09-1 ), welches von Givaudan unter der Marke Parsol® 1789 und von Merck unter der Handelsbezeichnung Eusolex® 9020 verkauft wird. Advantageous UV-A filter substances for the purposes of the present invention are dibenzoylmeter derivatives, in particular 4- (tert-butyl) -4'-methoxydibenzoylmethane (CAS No. 70356-09-1), which has been sold by Givaudan under the trademark Parsol ® 1789 and sold by Merck under the trade name Eusolex® 9020.
Vorteilhafte weitere UV-Filtersubstanzen im Sinne der vorliegenden Erfindung sind sulfo- nierte, wasserlösliche UV-Filter, wie z. B.: Advantageous further UV filter substances in the context of the present invention are sulfonated, water-soluble UV filters, such as. B .:
• Salze der 2-Phenylbenzimidazol-5-sulfonsäure, wie ihr Natrium-, Kalium- oder ihr Tri- ethanolammonium-Salz sowie die Sulfonsäure selbst mit der INCI Bezeichnung Phe- nylbenzimidazole Sulfonsäure (CAS. -Nr. 27503-81 -7), welches beispielsweise unter der Handelsbezeichnung Eusolex 232 bei Merck oder unter Neo Heliopan Hydro bei Haarmann & Reimer erhältlich ist; Salts of 2-phenylbenzimidazole-5-sulfonic acid, such as its sodium, potassium or triethanolammonium salt, and the sulfonic acid itself with the INCI name phenylbenzimidazole sulfonic acid (CAS No. 27503-81 -7), which is available, for example, under the trade name Eusolex 232 from Merck or under Neo Heliopan Hydro from Haarmann &Reimer;
• 1 ,4-di(2-oxo-10-Sulfo-3-bornylidenmethyl)-Benzol (auch: 3,3'-(1 ,4-Phenylendimethyl- ene)-bis-(7,7-dimethyl-2-oxo-bicyclo-[2.2.1 ]hept-1 -ylmethan Sulfonsäure) und dessen Salze (besonders die entprechenden 10-Sulfato-verbindungen, insbesondere das entsprechende Natrium-, Kalium- oder Triethanolammonium-Salz), das auch als Benzol- 1, 4-di (2-oxo-10-sulfo-3-bornylidenemethyl) benzene (also: 3,3 '- (1,4-phenylenedimethylene) -bis (7,7-dimethyl-2-) oxo-bicyclo [2.2.1] hept-1-ylmethane sulfonic acid) and its salts (especially the corresponding 10-sulfato compounds, in particular the corresponding sodium, potassium or triethanolammonium salt), also known as benzene
1 ,4-di(2-oxo-3-bornylidenmethyl-10-sulfonsäure) bezeichnet wird. Benzol-1 ,4-di(2-oxo-
3-bornylidenmethyl-10-sulfonsäure) hat die INCI-Bezeichnung Terephtalidene Di- campher Sulfonsäure (CAS. -Nr.: 90457-82-2) und ist beispielsweise unter dem Handelsnamen Mexoryl SX von der Fa. Chimex erhältlich. 1, 4-di (2-oxo-3-bornylidenemethyl-10-sulfonic acid) is called. Benzene-1, 4-di (2-oxo) 3-bornylidenemethyl-10-sulfonic acid) has the INCI name Terephtalidene Di-sulfo Sulfonic Acid (CAS No. 90457-82-2) and is available, for example, under the trade name Mexoryl SX from Chimex.
Vorteilhafte UV-Filtersubstanzen im Sinne der vorliegenden Erfindung sind ferner sogenannte Breitbandfilter, d.h. Filtersubstanzen, die sowohl UV-A- als auch UV-B-Strahlung absorbieren. Advantageous UV filter substances for the purposes of the present invention are also so-called broadband filters, i. Filter substances that absorb both UV-A and UV-B radiation.
Vorteilhafte Breitbandfilter oder UV-B-Filtersubstanzen sind beispielsweise Triazinderivate, wie z. B. Advantageous broadband filters or UV-B filter substances are, for example, triazine derivatives, such as. B.
• 2,4-Bis-{[4-(2-Ethyl-hexyloxy)-2-hydroxy]-phenyl}-6-(4-methoxyphenyl)-1 ,3,5-triazin (INCI: Aniso Triazin), welches unter der Handelsbezeichnung Tinosorb® S bei der CIBA-Chemikalien GmbH erhältlich ist; 2,4-bis - {[4- (2-ethyl-hexyloxy) -2-hydroxy] -phenyl} -6- (4-methoxyphenyl) -1, 3,5-triazine (INCI: aniso triazine), which available under the trade name Tinosorb® S from CIBA-Chemikalien GmbH;
• Diethylhexylbutylamidotriazon (INCI: Diethylhexylbutamidotriazone), welches unter der Handelsbezeichnung UVASORB HEB bei Sigma 3V erhältlich ist; Diethylhexylbutylamidotriazone (INCI: diethylhexylbutamidotriazone), which is available under the trade name UVASORB HEB from Sigma 3V;
4,4',4"-(1 ,3,5-Triazin-2,4,6-triyltriimino)-tris-benzoesäure-tris(2-ethylhexylester), auch: 2,4,6-Tris-[anilino-(p-carbo-2'-ethyl-1 '-hexyloxy)]-1 ,3,5-triazin (INCI: Ethylhexyl Tria- zone), welches von der BASF Aktiengesellschaft unter der Warenbezeichnung U- VINUL® T 150 vertrieben wird. 4,4 ', 4 "- (1,3,5-triazine-2,4,6-triyltriimino) tris-benzoic acid tris (2-ethylhexyl ester), also: 2,4,6-tris [anilino- (p-carbo-2'-ethyl-1'-hexyloxy)] - 1, 3,5-triazine (INCI: ethylhexyl triazone), which is sold by BASF Aktiengesellschaft under the trade name U-VINUL® T 150.
Ein vorteilhafter Breitbandfilter im Sinne der vorliegenden Erfindung ist auch das 2,2'-Methy- len-bis-(6-(2H-benzotriazol-2-yl)-4-(1 ,1 ,3,3-tetramethylbutyl)-phenol), welches unter der Handelsbezeichnung Tinosorb® M bei der CIBA-Chemikalien GmbH erhältlich ist. An advantageous broadband filter in the context of the present invention is also the 2,2'-methyl-bis (6- (2H-benzotriazol-2-yl) -4- (1,1,3,3-tetramethylbutyl) phenol ), which is available under the trade name Tinosorb® M from CIBA-Chemikalien GmbH.
Die nachfolgenden Beispiele sollen die vorliegende Erfindung verdeutlichen, ohne sie einzuschränken. Alle Mengenangaben, Anteile und Prozentanteile sind, soweit nicht anders angegeben, auf das Gewicht und die Gesamtmenge bzw. auf das Gesamtgewicht der Zubereitungen bezogen. The following examples are intended to illustrate the present invention without limiting it. Unless indicated otherwise, all amounts, proportions and percentages are based on the weight and the total amount or on the total weight of the preparations.
Zur Herstellung von 1 Kilogramm der erfindungsgemäßen Emulsionen werden die lipophile Phase (z.B. Öle, Wachse), Verdicker, Pigmente und die wässrige Phase separat eingewogen, wobei der nichtionische O/W-Emulgator zur lipophilen Phase (Ölphase) zugegeben wird, während die anionischen, wasserlöslichen Emulgatoren in die Wasserphase gegeben wurden. Die Ölphase wird bis auf 75°C in einem Wasserbad erhitz, um den Emulgator und
den Coemulgator zu lösen. Die Wasserphase wird ebenfalls bis auf 75°C unter Rühren erhitzt und danach wird sie nach der Zugabe der Verdickerphase unter intensivem Rühren langsam zur Ölphase hinzugegeben, wobei eine grobe Emulsion entsteht. Die Silica-be- schichteten anorganischen Pigmente werden in einem separaten Gefäß in ca. 100 ml einer Lösung aus Glycerin und Wassers mit einem hochtourigen Mixer (z.B. einem ESG Zauberstab) circa 2 Minuten intensiv homogenisiert und dann zur ca. 60 °C warmen Emulsion unter Rühren hinzugegeben. Die Emulsion wird dann ein erstes Mal homogenisiert und danach mit Natronlauge auf einen pH Wert von pH 6.5 - 7.3 neutralisiert. Nach Abkühlung der Emulsion auf Raumtemperatur erfolgt eine zweite Homogenisierung. To prepare 1 kilogram of the emulsions according to the invention, the lipophilic phase (eg oils, waxes), thickeners, pigments and the aqueous phase are weighed in separately, the nonionic O / W emulsifier being added to the lipophilic phase (oil phase), while the anionic, water-soluble emulsifiers were added to the water phase. The oil phase is heated to 75 ° C in a water bath to the emulsifier and to dissolve the coemulsifier. The water phase is also heated to 75 ° C with stirring and then it is slowly added after the addition of the thickener phase with intensive stirring to the oil phase, wherein a coarse emulsion is formed. The silica-coated inorganic pigments are intensively homogenized in a separate vessel in about 100 ml of a solution of glycerol and water with a high-speed mixer (eg an ESG wand) for about 2 minutes and then submerged to about 60 ° C warm emulsion Stirring added. The emulsion is then homogenized a first time and then neutralized with sodium hydroxide solution to a pH of pH 6.5 - 7.3. After the emulsion has cooled to room temperature, a second homogenization is carried out.
Zur Bestimmung der Lagerstabilität von den Pigmenten werden alle Emulsionsproben in verschraubten 30 mL Gläsern bei unterschiedlichen Temperaturen gelagert: bei Raumtemperatur (RT) (ca. 20°C), bei +40 °C, bei +50 °C sowie unter Wechseltemperaturbedingungen zwischen -10°C und +40°C. To determine the storage stability of the pigments, all emulsion samples are stored in screw-retained 30 mL glasses at different temperatures: at room temperature (RT) (about 20 ° C.), at + 40 ° C., at + 50 ° C. and under alternating temperature conditions between -10 ° C and + 40 ° C.
Die Stabilität wurde nach 7, 14, 21 und 30 Tagen (T) visuell bewertet.
The stability was assessed visually after 7, 14, 21 and 30 days (T).
Beispielrezeptur/ RT +40 °C + 50°C W-10 °C/ Temperaturen 40°CExample recipe / RT + 40 ° C + 50 ° C W-10 ° C / Temperatures 40 ° C
1 a - Emulsion mit Poly- Stabil 30T Stabil 30T Stabil 30T Stabil 30T glyceryl-3 Methylglu- cose Distearate und 1 a - Emulsion with PolyStable 30T Stabil 30T Stabil 30T Stabil 30T glyceryl-3 methylglucose distearate and
Pigmenten pigments
1 b - Emulsion 1 a Stabil 30T Stabil 30T Stabil 30T Stabil 30T ohne Piamente Nihiih El Iih Eltttconscemgaorenonscemgaorenuu-1 b - Emulsion 1 a Stable 30T Stable 30T Stable 30T Stable 30T without piamente N ihiih E l Iih E lttt conscem g ao r enonscem g ao r enuu
2a - Emulsion mit PEG- Stabil 30T Stabil 30T Stabil 30T Leichte In40 Stearate stabilität und Pigmenten 30T 2a - Emulsion with PEG-Stabil 30T Stabil 30T Stabil 30T Light In40 Stearate stability and pigments 30T
2b - Emulsion 2a Stabil 30T Stabil 30T Stabil 30T Stabil 30T ohne Piamente 2b - Emulsion 2a Stable 30T Stable 30T Stable 30T Stable 30T without Piamente
3a - Emulsion mit Gly- Stabil 30T Stabil 30T Leichte InstaStabil 30T cerylstearatcitrat und bilität 30T 3a - Emulsion with Gly-Stabil 30T Stabil 30T Light InstaStabil 30T ceryl stearate citrate and 30T
Pigmenten pigments
3b - Emulsion 3a ohne Stabil 30T Stabil 30T Stabil 30T Stabil 30T Pigmenten 3b - Emulsion 3a without Stabil 30T Stabil 30T Stabil 30T Stabil 30T pigments
4a - Emulsion mit Stabil 30T SedimentaSedimentation Leichte InSodium Stearoyl Glutation der Pigder Pigmente stabilität mate mente ab 21 T ab 21 T 30T und Pigmenten 4a - Emulsion with Stable 30T Sedimenta Sedimentation Slight InSodium Stearoyl Glutation of Pigder Pigments Stability Mate ments from 21 T from 21 T 30T and Pigments
4b - Emulsion 4a Stabil 30T Stabil 30T Stabil 30T Stabil 30T ohne Piqmente 4b - Emulsion 4a Stable 30T Stable 30T Stable 30T Stable 30T without Piqmente
5a - Emulsion mit SoLeichte InSedimentaSedimentation Stabil 30T dium Cetearyl Sulfate stabilität tion der Pigder Pigmente 5a - Emulsion with SoLight InSedimenta Sedimentation Stable 30T dium Cetearyl Sulfate Stability of Pigder Pigments
und Pigmenten 30T mente ab 14T ab 14T and pigments 30T from 14T from 14T
5b - Emulsion 5a Leichte InStabil 30T Stabil 30T Stabil 30T ohne Piamente stabilität 5b - Emulsion 5a Light InStable 30T Stabil 30T Stabil 30T without Piamente stability
30T 30T
„Stabil" bedeutet, dass keine oder nur geringe Phasentrennung, keine oder nur geringe Ölab- scheidung, keine visuell erkennbaren Inhomogenität der Pigmentverteilung auftritt.„Leichte Instabilität" bedeutet, dass es zu einer moderaten, sichtbaren Phasentrennung oder deutlich sichtbaren Ölabscheidung oder zu visuell erkennbaren Inhomogenität kommt.
„Sedimentation der Pigmente" bedeutet, vollständige und sichtbare Sedimentation der Pigmente am Boden. "Stable" means no or little phase separation, little or no oil separation, no visually discernible inhomogeneity of the pigment distribution. "Light instability" means that there is a moderate, visible phase separation or clearly visible oil separation or visually discernible Inhomogeneity is coming. "Sedimentation of the pigments" means complete and visible sedimentation of the pigments on the soil.
Diese Experimente haben gezeigt, dass die Silica beschichtete anorganischen Pigmente Emulsionen durch die nichtionischen Emulgatoren stabilisiert wurden. These experiments have shown that the silica-coated inorganic pigments emulsions have been stabilized by the non-ionic emulsifiers.
Caprylic/Capric Triglyceride 4Caprylic / Capric Triglycerides 4
Stearylalkohol 2Stearyl alcohol 2
Phenoxyethanol 0.8Phenoxyethanol 0.8
Dicaprylyl Ether 4Dicaprylyl ether 4
Carbomer 0.1Carbomer 0.1
Glycerin 7Glycerol 7
Natronlauge (45%-ig) 0,13Sodium hydroxide solution (45%) 0.13
Silica beschichtete anorganischen Pigmente 6 [(Cl 77499, Cl 77491 , Cl 77891 , Cl 77492) Silica coated inorganic pigments 6 [(Cl 77499, Cl 77491, Cl 77891, Cl 77492)
+ Silica] - PRIMROSE + Silica] - PRIMROSE
Wasser Ad 100 Water Ad 100
Polyglyceryl-10 Stearat 1Polyglyceryl-10 Stearate 1
Glyceryl Stearate 2Glyceryl Stearate 2
Cetylalkohol 1Cetyl alcohol 1
Octyldodecanol 3Octyldodecanol 3
Cetearyl Isononanoate 4Cetearyl Isononanoate 4
C12-15 Alkylbenzoat 2C12-15 alkyl benzoate 2
Bis-Ethylhexyloxyphenolmethoxyphenyltria- 1 zin Bis-ethylhexyloxyphenolmethoxyphenyltria-1-zine
Octocrylen 5 Octocrylene 5
Phenoxyethanol 0.5Phenoxyethanol 0.5
Methylpropandiol 0.2Methylpropanediol 0.2
Xanthan Gum 0.2Xanthan gum 0.2
Acrylates/C 10-30 Alkyl Acrylate Crosspoly- 0.2 mer Acrylates / C 10-30 alkyl acrylate cross-poly-0.2 mer
Glycerin 6 Glycerol 6
Benzylalkohol 0.1Benzyl alcohol 0.1
Natronlauge (45%-ig) 0,13Sodium hydroxide solution (45%) 0.13
Silica beschichtete anorganischen Pigmente 5 Silica coated inorganic pigments 5
[(Cl 77499, Cl 77491 , Cl 77891 , Cl 77492) [(Cl 77499, Cl 77491, Cl 77891, Cl 77492)
+ Silica] - PRIMROSE + Silica] - PRIMROSE
Wasser Ad 100
Water Ad 100
Claims
Kosmetische oder dermatologische Zubereitungen enthaltend Contains cosmetic or dermatological preparations
a) Mindestens ein Pigment aus der Gruppe der anorganischen Weiß-, Färb- oder Buntpigmente, welche mit hydrophilem Silica beschichtet sind und a) at least one pigment from the group of inorganic white, colored or colored pigments, which are coated with hydrophilic silica and
b) einen oder mehrere nichtionischen Emulgatoren b) one or more nonionic emulsifiers
Zubereitungen nach Anspruch 1 , dadurch gekennzeichnet, dass der oder die nichtionischen Emulgatoren gewählt werden aus den Gruppen Preparations according to claim 1, characterized in that the one or more nonionic emulsifiers are selected from the groups
a) Partialfettsäureester und Fettsäureester mehrwertiger Alkohole und deren ethoxylierten Derivate (z. B. Glycerylmonostearat, Sorbitanstearat, Glyceryl- stearatcitrat, Sucrose Stearate) a) Partial fatty acid esters and fatty acid esters of polyhydric alcohols and their ethoxylated derivatives (for example glyceryl monostearate, sorbitan stearate, glyceryl stearate citrate, sucrose stearate)
b) Ethoxylierte Fettalkohole bzw. Fettsäuren, bevorzugt PEG-100-Stearat, PEG- 40-Stearat, Ceteareth-20, Ceteth-20, Steareth-20, Ceteareth-12, Ceteth-12, Steareth-12 sowie Ester aus Mono-, Oligo- oder Polysacchariden mit Fettsäuren, bevorzugt Cetearylglucosid und Methylglucosedistearat. b) ethoxylated fatty alcohols or fatty acids, preferably PEG-100 stearate, PEG-40 stearate, ceteareth-20, ceteth-20, steareth-20, ceteareth-12, ceteth-12, steareth-12 and also esters of mono-, Oligo- or polysaccharides with fatty acids, preferably cetearyl glucoside and methyl glucose distearate.
c) Fettsäureester von Oligoglycerinen sowie Gemischen aus den unter a), b) und c) bezeichneten Substanzen. c) fatty acid esters of oligoglycerols and mixtures of the substances mentioned under a), b) and c).
Zubereitungen nach Anspruch 1 oder 2, dadurch gekennzeichnet, dass der oder die nichtionischen Emulgatoren gewählt wird oder werden aus der Gruppe Glycerylstea- ratcitrat, Polyglyceryl-3 Methylglucosedistearat, Polyglyceryl-10 Stearat, PEG-40-Stea- rat. Preparations according to Claim 1 or 2, characterized in that the nonionic emulsifier (s) is / are selected from the group of glyceryl stearate citrate, polyglyceryl-3-methylglucose distearate, polyglyceryl-10-stearate, PEG-40 stearate.
Zubereitungen nach einem der vorstehenden Ansprüche, dadurch gekennzeichnet, dass sie 0,01 - 20 Gew.-%, bevorzugt 0,05 - 10 Gew.-%, besonders bevorzugt 0,1 - 5 Gew.-% an einem oder mehreren der erfindungsgemäßen nichtionischen Emulgatoren enthalten, bezogen auf die Gesamtzusammensetzung der Zubereitungen, insbesondere eine oder mehrere Substanzen, gewählt aus einer oder mehrerer der unter a) bis c) genannten Gruppen, ganz besonders bevorzugt eine oder mehrere Substanzen, gewählt aus der Gruppe Glycerylstearatcitrat, Polyglyceryl-3 Methylglucosedistearat, Polyglyceryl-10 Stearat, und/oder PEG-40-Stearat. Preparations according to one of the preceding claims, characterized in that they contain 0.01 to 20 wt.%, Preferably 0.05 to 10 wt.%, Particularly preferably 0.1 to 5 wt.% Of one or more of the present invention nonionic emulsifiers, based on the total composition of the preparations, in particular one or more substances selected from one or more of the groups mentioned under a) to c), most preferably one or more substances selected from the group glyceryl stearate citrate, polyglyceryl-3 methyl glucose distearate , Polyglyceryl-10 stearate, and / or PEG-40 stearate.
Zubereitungen nach einem der vorstehenden Ansprüche, dadurch gekennzeichnet, dass sie 0,01 - 50 Gew.-%, bevorzugt 0,05 - 30 Gew.-%, besonders bevorzugt 0,1 - 20 Gew.-% an einem oder mehreren der erfindungsgemäßen Pigment aus der Gruppe
der anorganischen Weiß-, Färb- oder Buntpigmente, welche mit hydrophilem Silica beschichtet sind, enthalten, bezogen auf die Gesamtzusammensetzung der Zubereitungen. Preparations according to one of the preceding claims, characterized in that they are 0.01-50 wt .-%, preferably 0.05-30 wt .-%, particularly preferably 0.1-20 wt .-% of one or more of the inventive Pigment from the group of the inorganic whitening, coloring or colored pigments coated with hydrophilic silica, based on the total composition of the preparations.
6. Verwendung von nichtionischen Emulgatoren, wie in den vorstehenden Ansprüchen beschrieben, zur Verbesserung der Einarbeitbarkeit, von mit hydrophilem Silica beschichteter Metalloxidpartikel, wie in den vorstehenden Ansprüchen beschrieben.
Use of nonionic emulsifiers as described in the preceding claims for improving the incorporation of hydrophilic silica-coated metal oxide particles as described in the preceding claims.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP18700101.1A EP3585353A1 (en) | 2017-02-27 | 2018-01-05 | Cosmetic or dermatological preparations containing inorganic pigments which are coated with hydrophobic silica, and non-ionic emulsifiers |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102017203115.8A DE102017203115A1 (en) | 2017-02-27 | 2017-02-27 | Cosmetic or dermatological preparations containing inorganic pigments coated with hydrophilic silica and non-ionic emulsifiers |
DE102017203115.8 | 2017-02-27 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2018153556A1 true WO2018153556A1 (en) | 2018-08-30 |
Family
ID=60937771
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2018/050269 WO2018153556A1 (en) | 2017-02-27 | 2018-01-05 | Cosmetic or dermatological preparations containing inorganic pigments which are coated with hydrophobic silica, and non-ionic emulsifiers |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP3585353A1 (en) |
DE (1) | DE102017203115A1 (en) |
WO (1) | WO2018153556A1 (en) |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0009801A1 (en) | 1978-10-10 | 1980-04-16 | Sterling Drug Inc. | Pharmaceutical compositions containing polycyclic cyanoketones |
EP0009701A1 (en) | 1978-09-28 | 1980-04-16 | RHEIN-CHEMIE RHEINAU GmbH | Sulfur-containing reaction products, method for their preparation and their use as lubricant additives |
US20070104677A1 (en) * | 2004-04-02 | 2007-05-10 | Barbara Dold | Preparation in the form of an emulsion |
DE102009060148A1 (en) * | 2009-12-23 | 2011-06-30 | Beiersdorf AG, 20253 | Cosmetic oil/water-emulsion, useful to obtain consistent skin texture after applying the emulsion on the skin, comprises pigment including inorganic white-, color- and/or multicolored pigments, and a pearlescent pigment |
EP2364688A2 (en) * | 2010-03-12 | 2011-09-14 | Beiersdorf AG | Cosmetic preparations with highly elastic texture |
DE102014203868A1 (en) * | 2014-03-04 | 2015-09-10 | Evonik Degussa Gmbh | Polyglycerol ester with particular oligomer distribution of polyglycerol |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9616978D0 (en) | 1996-08-13 | 1996-09-25 | Tioxide Specialties Ltd | Zinc oxide dispersions |
US8277785B2 (en) | 2005-12-13 | 2012-10-02 | Avon Products, Inc. | Cosmetic compositions with encapsulated pigments and a method for using |
DE202006011834U1 (en) | 2006-08-02 | 2006-09-28 | Beiersdorf Ag | Cosmetic preparation, useful in sun protective agent, comprises a benzoyl compound and hydrophilic micro pigments |
DE102007055008A1 (en) | 2007-11-14 | 2009-06-10 | Coty Prestige Lancaster Group Gmbh | Cosmetic product for the protection of the skin against environmental influences |
-
2017
- 2017-02-27 DE DE102017203115.8A patent/DE102017203115A1/en not_active Withdrawn
-
2018
- 2018-01-05 WO PCT/EP2018/050269 patent/WO2018153556A1/en active Application Filing
- 2018-01-05 EP EP18700101.1A patent/EP3585353A1/en not_active Withdrawn
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0009701A1 (en) | 1978-09-28 | 1980-04-16 | RHEIN-CHEMIE RHEINAU GmbH | Sulfur-containing reaction products, method for their preparation and their use as lubricant additives |
EP0009801A1 (en) | 1978-10-10 | 1980-04-16 | Sterling Drug Inc. | Pharmaceutical compositions containing polycyclic cyanoketones |
US20070104677A1 (en) * | 2004-04-02 | 2007-05-10 | Barbara Dold | Preparation in the form of an emulsion |
DE102009060148A1 (en) * | 2009-12-23 | 2011-06-30 | Beiersdorf AG, 20253 | Cosmetic oil/water-emulsion, useful to obtain consistent skin texture after applying the emulsion on the skin, comprises pigment including inorganic white-, color- and/or multicolored pigments, and a pearlescent pigment |
EP2364688A2 (en) * | 2010-03-12 | 2011-09-14 | Beiersdorf AG | Cosmetic preparations with highly elastic texture |
DE102014203868A1 (en) * | 2014-03-04 | 2015-09-10 | Evonik Degussa Gmbh | Polyglycerol ester with particular oligomer distribution of polyglycerol |
Non-Patent Citations (2)
Title |
---|
MIYOSHI EUROPE: "PRIMROSE Silica-Coated Pigments", 19 January 2017 (2017-01-19), pages 1 - 2, XP055453663, Retrieved from the Internet <URL:http://web.archive.org/web/20170119191944/http://miyoshiamerica.com/wp-content/uploads/2016/01/PRIMROSE-v1.3-LR-MAI.pdf> [retrieved on 20180222] * |
MIYOSHI EUROPE: "Silica Beads Highly Pure Spherical Silic Beads", SAGE OPEN, 1 March 2015 (2015-03-01), Los Angeles, CA, XP055452897, Retrieved from the Internet <URL:http://www.cossma.com/fileadmin/all/cossma/Archiv/ProductInfo/COS1604_70SilicaBead.pdf> [retrieved on 20180221], DOI: 10.1177/2158244014536405 * |
Also Published As
Publication number | Publication date |
---|---|
EP3585353A1 (en) | 2020-01-01 |
DE102017203115A1 (en) | 2018-08-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60001345T2 (en) | At least one insoluble organic UV filter and an associative polymer containing emulsions | |
EP2111847A1 (en) | Hydrocarbon mixtures and their use | |
EP1641904B1 (en) | O/w emulsifier, o/w emulsion and applications thereof | |
DE10321147A1 (en) | Stabilization of self-tanning products with layered silicates | |
EP1301166A1 (en) | Rendering sunscreen agents visible on the skin | |
WO2018060018A1 (en) | Use of dialkyl carbonates of branched alcohols as a dispersant | |
DE102008022434A1 (en) | Cosmetic preparations containing hydrocarbons | |
DE102005051869A1 (en) | Cosmetic preparation, useful e.g. for the protection of skin and (semi)mucous membrane against bacteria and/or virus, comprises violacein dye in combination with lipophilic and/or hydrophilic substances | |
EP1013262A2 (en) | Cosmetic and dermatologic o/w-emulsions containing boron nitride | |
EP0887068B1 (en) | Use of beeswax to increase the protection factor of cosmetic or dermatological sunscreens | |
DE19703471A1 (en) | Cosmetic and dermatological sunscreen formulations containing triazine derivatives and butylene glycol diesters | |
EP0887069B1 (en) | Use of synthetic beeswax to increase the protection factor of cosmetic or dermatological sunscreens | |
CH713170B1 (en) | Cosmetic or dermatological preparation containing an aqueous and a lipophilic fish extract. | |
EP0935959B1 (en) | Use of beeswax to increase the UVA protection factor of cosmetic or dermatologic sunscreens | |
EP0826360B1 (en) | Use of dibenzoyl methane derivatives to attain or improve the solubility of triazine derivatives in oils | |
WO2018153556A1 (en) | Cosmetic or dermatological preparations containing inorganic pigments which are coated with hydrophobic silica, and non-ionic emulsifiers | |
DE19723732A1 (en) | Use of mono-acyl esters of isosorbide | |
AU2006297609A1 (en) | Cosmetic compostions having increased color intensity and method for producing same | |
DE10035512A1 (en) | Use of dyes in cosmetic and dermatological sunscreen formulations to make them visible on skin | |
DE202007019599U1 (en) | Use of cosmetic or dermatological preparations containing glycyrrhetin and / or glycyrrhizin and 2,4-bis- {I4- (2-ethylhexyloxy) -2-hydroxyl-1-phenyl} -6- (4-methoxyphenyl) -1,3,5-triazine Increase in the pigmentation of the human skin | |
EP0895775B1 (en) | Lightprotection compositions containing inorganic pigments which are coated on their surface with UV filter substances | |
EP3570812B1 (en) | Cosmetic preparations containing sphereic silicone materials coated with titanium dioxide and iron oxides and medium-chained aliphatic dioles | |
DE19900094B4 (en) | Process for the preparation of sunscreen preparations comprising organic UV filters in solid, finely divided form | |
DE19645320A1 (en) | Active agent combination for foaming pharmaceuticals and cosmetics | |
DE19830461A1 (en) | Use of iron-titanium mixed oxides to enhance the sun protection performance of cosmetic or dermatological sunscreens |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 18700101 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2018700101 Country of ref document: EP |